References Which Document ALZET® Osmotic Pump Functionality

One of the best methods for verifying correct operation of the pumps is to monitor blood or plasma levels of the drug administered at several points during the course of administration. In the event that determination of circulating blood levels is not possible or is technically undesirable, another method of verifying pump functionality is to measure the residual drug solution left in the pump reservoir at the time the pump is explanted. This can be done by aspirating the solution from the reservoir using a syringe and filling tube (provided with each box of pumps). If the remaining volume is approximately 5% of the original volume, you can assume that the pump has worked accordingly to specifications.

The references in this sub-bibliography detail residual volume, or blood or systemic drug concentration measurements, which verified that ALZET pumps functioned properly. The short abstract that accompanies each reference details the substance(s) infused, the route of administration and animal model used, the vehicle for infusion, the pump model used, duration of infusion, and notable technical achievements or results.

For a more complete discussion of the capabilities of ALZET osmotic pump infusion, consult the following references:
Theeuwes, F., and Yum, S.I. (1976). Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann. Biomed. Eng. 4(4), 343-353.

Urquhart, J., Fara, J., and Willis, K.L. (1984). Rate-controlled delivery systems in drug and hormone research. Ann. Rev. Pharmacol. Toxicol. 24, 199-236.

To obtain a complete list of citations pertaining to extended duration studies published since 1975, please contact ALZET Technical Services at (800) 692-2990 (U.S. & Canada), or (408) 367-4036. You may also contact us via e-mail at alzet@durect.com.

Citations from 2005-2007

P8876 Viquez,O.M., Valentine,H.L., Amarnath,K., Milatovic,D., Valentine,W.M. Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy. TOXICOLOGY AND APPLIED PHARMACOLOGY 2008; 229(-1-):77-85. >>> Diethyldithiocarbamate, sodium; Intra-abdominal; Rat; 2ML4; 2, 4, 8 weeks; Functionality of mp verified by residual volume, visual inspection for blockage; long-term study; pumps replaced after 4 weeks; animal info (male, Sprague Dawley).

P8866 Terao,S., Yilmaz,G., Stokes,K.Y., Ishikawa,M., Kawase,T., Granger,D.N. Inflammatory and injury responses to ischemic stroke in obese mice. Stroke 2008; 39(-3-):943-950. >>> Leptin, mouse; SC; Mice; 1003D; 3 days; Functionality of mp verified by plasma leptin levels; peptides; post op. care (neomycin trisulfate salt hydrate); animal info (young, 5-7 wks old, ob/ob); obesity.

P8852 Wang,H.Y., Ghosh,A., Baigude,H., Yang,C.S., Qiu,L.H., Xia,X.G., Zhou,H.X., Rana,T.M., Xu,Z.S. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression. Journal of Biological Chemistry 2008; 283(-23-):15845-15852. >>> RNA, small interfering, modified; RNA, small interfering; PBS; CSF/CNS (intrathecal, subarchanoid space); Mice (transgenic); 1007D; 2004; 7, 28 days; 72 hours; Controls received mp w/ vehicle; functionality of mp verified by residual volume; dose-response (Fig. 3); no stress (see pg. 15846, 15849); stability verified by 28 days in vivo (see Fig. 2); half-life (p. 15846) "short"; gene therapy; brain tissue distribution; animal info (SOD1G93A Tg); neurodegenerative (ALS); mp + catheter positioning confirmed; Target (SOD1); "when infused at disease onset at the therapeutic dose for 4 weeks, this siRNA slows disease progression without detectable adverse effects.".

P8849 LaCroix,C., Freeling,J., Giles,A., Wess,J., Li,Y.F. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. American Journal of Physiology-Heart and Circulatory Physiology 2008; 294(-2-):H810-H820. >>> Isoproterenol; SC; Mice; 1 week; Controls received mp w/ saline; functionality of mp verified by residual volume; comparison of IV injections vs. mp; cardiovascular; animal info (male, 129J1 x CF1, wt, M2-AChR -/-, 2-3 months old, 30g.).

P8844 Pozdeyev,N., Tosini,G., Li,L., Ali,F., Rozov,S., Lee,R.H., Iuvone,P.M. Dopamine modulates diurnal and circadian rhythms of protein phosphorylation in photoreceptor cells of mouse retina. European Journal of Neuroscience 2008; 27(-10-):2691-2700. >>> L-745,870; Cyclodextrin, 2-hydroxypropyl, beta; SC; Mice; 1003D; 2 days; Controls received mp w/ vehicle; functionality of mp verified by agent levels in retina; animal info (C3H/ft/t); L-745,870 is a dopamine D4 receptor antagonist.

P8838 Singhal,R., Shankar,K., Badger,T.M., Ronis,M.J. Estrogenic status modulates aryl hydrocarbon receptor - mediated hepatic gene expression and carcinogenicity. Carcinogenesis 2008; 29(-2-):227-236. >>> Estradiol; SC; Rat; 2002; 15 days; Controls received mp w/ PEG; functionality of mp verified by serum E2 levels; replacement therapy (ovariectomy); animal info (female, Sprague Dawley, 50 days old).

P8819 Kudlacz,E., Conklyn,M., Andresen,C., Whitney-Pickett,C., Changelian,P. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. European Journal of Pharmacology 2008; 582(-1-3-):154-161. >>> CP-690550; Water, distilled; ethanol; SC; Mice; 2001; 2002; 3, 14 days; Controls received mp w/ vehicle; functionality of mp verified by plasma agent levels; dose-response (Fig. 6); enzyme inhibitor (Janus Kinase 3 (JAK-3)); animal info (female, Balb/c wt, IL-4 -/-, 4-6 wks old); 5% EtOH used.

P8815 Jin,H.K., Yang,R.H., Zheng,Z., Romero,M., Ross,J., Bou-Reslan,H., Carano,R.A.D., Kasman,I., Mai,E., Young,J., Zha,J.P., Zhang,Z.M., Ross,S., Schwall,R., Colbern,G., Merchant,M. MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival. Cancer Research 2008; 68(-11-):4360-4368. >>> Hepatocyte growth factor, human; Dextran sulfate; IP; Mice (nude); 1002; ; Controls received mp w/ vehicle; functionality of mp verified by human HGF serum levels; long-term study; pumps replaced every 12 to 14 days; cancer (pancreatic); peptides; animal info (female, nu/nu).

P8795 Takata,Y., Liu,J., Yin,F., Collins,A.R., Lyon,C.J., Lee,C.H., Atkins,A.R., Downes,M., Barish,G.D., Evans,R.M., Hsueh,W.A., Tangirala,R.K. PPAR delta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2008; 105(-11-):4277-4282. >>> Angiotensin II; PBS; SC; Mice; 4 weeks; Controls received mp w/ vehicle; functionality of mp verified by blood pressure; animal info (LDLR -/-, 3 mos); pump model not specified.

P8787 Sharma,U., Rhaleb,N.E., Pokharel,S., Harding,P., Rasoul,S., Peng,H.M., Carretero,O.A. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. American Journal of Physiology-Heart and Circulatory Physiology 2008; 294(-3-):H1226-H1232. >>> Angiotensin II; peptide, Ac-SDKP; Saline; acetic acid; SC; Mice; 2004; 8 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; long-term study; pumps replaced after 4 weeks; cardiovascular; peptides; animal info (male, C57BL6/J, 12-14 wks old).

P8781 Graciano,M.L., Nishiyama,A., Jackson,K., Seth,D.M., Ortiz,R.M., Prieto-Carrasquero,M.C., Kobori,H., Navar,L.G. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. American Journal of Physiology-Renal Physiology 2008; 294(-1-):F161-F169. >>> Angiotensin II; SC; Rat; 14 days; Controls received sham surgery; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague Dawley, 200-250g.).

P8775 Roa,J., Vigo,E., Garcia-Galiano,D., Castellano,J.M., Navarro,V.M., Pineda,R., Dieguez,C., Aguilar,E., Pinilla,L., Tena-Sempere,M. Desensitization of gonadotropin responses to kisspeptin in the female rat: analyses of LH and FSH secretion at different developmental and metabolic states. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2008; 294(-6-):E1088-E1096. >>> Kisspeptin-10; Leptin; Saline, physiological; CSF/CNS; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by response duration and examination; stability verified by persistent FSH response; peptide; animal info (female, Wistar, 205-275 g., adult, 110-120g., 30 days old).

P8773 Lu,H., Rateri,D.L., Feldman,D.L., Charnigo,RJ Jr, Fukamizu,A., Ishida,J.J., Oesterling,E.G., Cassis,L.A., Daugherty,A. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. Journal of Clinical Investigation 2008; 118(-3-):984-993. >>> Aliskiren; PBS; SC; Mice; 2004; 4, 12 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma Aliskiren levels; dose-response (fig. 1); long-term study; pumps replaced every 28 days; no stress (see pg. 985); enzyme inhibitor (Renin); cardiovascular; animal info (male, C57BL/6, Ldlr -/-, 6-8 wks old, 30g.).

P8766 King,A.J., Novotny,M., Swain,G.M., Fink,G.D. Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2008; 294(-4-):R1262-R1267. >>> Angiotensin II; SC; Rat; 2ML2; 14 days; Functionality of mp verified by mean arterial blood pressure; cardiovascular; peptides; animal info (male, Sprague Dawley, 225-250g.).

P8764 Klieverik,L.P., Sauerwein,H.P., Ackermans,M.T., Boelen,A., Kalsbeek,A., Fliers,E. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2008; 294(-3-):E513-E520. >>> Thyroxine, L-; Propylene glycol; NaOH; SC; Rat; 2ML2; 10 days; Functionality of mp verified by T4 plasma concentrations; dose-response (Fig. 1); no stress (see pg. E515); post op. care (Temgesic); animal info (male, Wistar, 325-375g.); hepatic sympathetic or parasympathetic denervation.

P8753 Koch,L., Wunderlich,F.T., Seibler,J., Konner,A.C., Hampel,B., Irlenbusch,S., Brabant,G., Kahn,C.R., Schwenk,F., Bruening,J.C. Central insulin action regulates peripheral glucose and fat metabolism in mice. Journal of Clinical Investigation 2008; 118(-6-):2132-2147. >>> Leptin; insulin; SC; CSF/CNS; Mice; 1002; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by serum leptin levels; ALZET brain infusion kit 3 used; peptides; cyanoacrylate adhesive; animal info (C57BL/6, wt, IR-d-wb, 10-14 wks old); cannula position confirmed post mortem with methylene blue.

P8752 Marko,S.B., Damon,D.H. VEGF promotes vascular sympathetic innervation. American Journal of Physiology-Heart and Circulatory Physiology 2008; 294(-6-):H2646-H2652. >>> Antibody, anti-VEGF (164 and 120); immunoglobulin G; PBS; Dye, Evans blue; SC; Rat; 1002; 4, 7, 14, 21 days; Controls received mp w/ control IgG; functionality of mp verified by distribution of dye within surgical area; cardiovascular; animal info (male, Sprague Dawley, denervated femor of artery).

R0245 Parsons,C.G., Stoeffler,A., Danysz,W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system - too little activation is bad, too much is even worse. Neuropharmacology 2007; 53(-6-):699-723. >>> Memantine; SC; Rat; 2ML2; 1 week; Functionality of mp verified by plasma levels; learning; memory; review p. 703.

P8890 Hobara,N., Goda,M., Yoshida,N., Takatori,S., Kitamura,Y., Mio,M., Kawasaki,H. Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries. Neuroscience 2007; 150(-3-):730-741. >>> Angiotensin II; nerve growth factor; PD123319; losartan; Saline; water; IP; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; peptides; post op. care (penicillin); animal info (8 wks old, Wistar).

P8823 Cariou,B., Bouchaert,E., Abdelkarim,M., Dumont,J., Caron,S., Fruchart,J.C., Burcelin,R., Kuipers,F., Staels,B. FXR-deficiency confers increased susceptibility to torpor. FEBS Letters 2007; 581(-27-):5191-5198. >>> Leptin, recomb. mouse; SC; 1003D; 3 days; Controls received mp w/ sterile saline; functionality of mp verified by plasma leptin levels; peptides; animal info (female, C57BL/6, wt, FXR -/-).

P8750 Muether,P.S., Dell,S., Kociok,N., Zahn,G., Stragies,R., Vossmeyer,D., Joussen,A.M. The role of integrin alpha5beta1 in the regulation of corneal neovascularization. Experimental Eye Research 2007; 85(-3-):356-365. >>> JSM5562; Saline; DMSO; IP; Mice; 2001; 7 days; Controls received mp w/ control substance; functionality of mp verified by serum agent levels; dose-response (fig. 3); no stress (see pg. 360); animal info (female, C57BL/6, 20-25g); integrin antagonist; 50% DMSO; "All doses were well tolverated over the 7 days of treament period." (p. 360).

P8748 Kilic,A., Bubikat,A., Gassner,B., Baba,H.A., Kuhn,M. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling. Endocrinology 2007; 148(-9-):4162-4169. >>> Angiotensin II; Saline; acetic acid; SC; Mice; 2002; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by arterial blood pressure; cardiovascular; peptides; animal info (CM GC-A KO, wt; male, female, 8-12 weeks old).

P8745 Wakisaka,O., Takahashi,N., Shinohara,T., Ooie,T., Nakagawa,M., Yonemochi,H., Hara,M., Shimada,T., Saikawa,T., Yoshimatsu,H. Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. Journal of Molecular and Cellular Cardiology 2007; 43(-5-):616-626. >>> Angiotensin II; SC; Rat; 2ML4; 28 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; no stress (see pg. 624); cardiovascular; peptides; animal info (male, Sprague-Dawley, 250-300g); "In our continuous AII infusion model, no overt heart failure was observed." (p. 624).

P8736 Zavros,Y., Waghray,M., Tessier,A., Bai,L.C., Todisco,A., Gumucio,D.L., Samuelson,L.C., Dlugosz,A., Merchant,J.L. Reduced pepsin a processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation. Journal of Biological Chemistry 2007; 282(-46-):33265-33274. >>> Gastrin-17, rat; gastrin-17 gly; IP; Mice; 1002; 14 days; Functionality of mp verified by plasma gastrin levels; peptides; animal info (C57BL/6 x 129/SV, G -/-, wt, 8 weeks old).

P8730 McBryde,F.D., Guild,S.J., Barrett,C.J., Osborn,J.W., Malpas,S.C. Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits. Experimental Physiology 2007; 92(-5-):831-840. >>> Angiotensin II; IV (jugular); Rabbit; 2ML4; 3 weeks; Functionality of mp verified by mean arterial pressure; dose-response (fig. 1); cardiovascular; peptides; animal info (New Zealand White, 2.4-3.5 kg).

P8723 Brandt,C., Glien,M., Gastens,A.M., Fedrowitz,M., Bethmann,K., Volk,H.A., Potschka,H., Loescher,W.F. Prophylactic treatment with levetiracetam after status epilepticus: Lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 2007; 53(-2-):207-221. >>> Levetriacetam; Water, distilled; SC; Rat; 2ML2; 8 weeks; Controls received mp w/ saline; functionality of mp verified by residual volume; long-term study; pumps replaced three times every 14 days; stress/adverse reaction (see pg. 210); half life (p. 209) 2-3 hours; animal info (female, Sprague-Dawley, 200-200g, epileptic); levetiracetam is an antiepileptic drug.

P8719 Hoeger,S., Gottmann,U., Liu,Z., Schnuelle,P., Birck,R., Braun,C., van der Woude,F.J., Yard,B.A. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. TRANSPLANT INTERNATIONAL 2007; 20(-9-):790-799. >>> Dopamine; IV (femoral); Rat; 2ML1; 24 hours; Functionality of mp verified by blood pressure; animal info (male, Fisher, 200-250g).

P8715 Cao,R.Y., Adams,M.A., Habenicht,A.J., Funk,C.D. Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. PROSTAGLANDINS&OTHER LIPID MEDIATORS 2007; 84(-1-2-):34-42. >>> Angiotensin II; SC; Mice; 2004; 28 days; Functionality of mp verified by residual volume analysis; blood pressure taken; cardiovascular; peptides; animal info (male, 8 weeks old).

P8713 Kusari,J., Zhou,S., Padillo,E., Clarke,K.G., Gil,D.W. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. INVESTIGATIVE OPHTHALMOLOGY&VISUAL SCIENCE 2007; 48(-11-):5152-5159. >>> Memantine; Water, distilled; SC; Rat; 2ML2; 3-4 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma MEM levels; pumps replaced after 2 weeks; animal info (male, Brown Norway, 250-300g); diabetes.

P8705 Mizuno,M., Sotoyama,H., Narita,E., Kawamura,H., Namba,H., Zheng,Y.J., Eda,T., Nawa,H. A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. Journal of Neuroscience 2007; 27(-38-):10116-10127. >>> Epidermal growth factor, recomb. human; Saline; CSF/CNS (striatum); CSF/CNS (nucleus accumbens); Rat; 2002; 8-14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; dose-response (fig. 1); peptides; multiple pumps per animal (2); post op. care (cefmetazon); animal info (male, Sprague-Dawley, 7-8 wks old, 300-380g); cannula position confirmed after completion of tests.

P8700 Hindlet,P., Bado,A., Farinotti,R., Buyse,M. Long-term effect of leptin on H+ -coupled peptide cotransporter 1 activity and expression in vivo: Evidence in leptin-deficient mice. Journal of Pharmacology and Experimental Therapeutics 2007; 323(-1-):192-201. >>> Leptin, recomb.; PBS; SC; Rat; mice; 1007D; 2ML1; 7 days; Controls received mp w/ vehicle; functionality of mp verified by plasma leptin levels; peptides; animal info (male, Wistar, 250-275g; male, C57BL/6J, wt, ob/ob, 7 wks old).

P8689 White,C.A., Zhang,J.G., Salamonsen,L.A., Baca,M., Fairlie,W.D., Metcalf,D., Nicola,N.A., Robb,L., Dimitriadis,E. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: A nonhormonal contraceptive strategy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2007; 104(-49-):19357-19362. >>> Leukemia inhibitory factor, antagonist; PBS; IP; Mice; ; Functionality of mp verified by plasma levels taken; comparison of SC/IP injections vs. mp; animal info (8-10 wk old, female, C57BL/6J).

P8688 Roth,J.D., Coffey,T., Jodka,C.M., Maier,H., Athanacio,J.R., Mack,C.M., Weyer,C., Parkes,D.G. Combination therapy with amylin and peptide YY[3-36] in obese rodents: Anorexigenic synergy and weight loss additivity. Endocrinology 2007; 148(-12-):6054-6061. >>> Amylin; peptide YY (3-36), human; DMSO; SC; Rat; mice; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; dose-response (fig. 2, p. 6057); peptides; animal info (rats, DIO prone; mice, DIO, C57BL/6J); 50% DMSO in water.

P8686 Harris,R.B.S., Bartness,T.J., Grill,H.J. Leptin responsiveness in chronically decerebrate rats. Endocrinology 2007; 148(-10-):4623-4633. >>> Leptin; PBS; IP; Rat; 2002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by serum levels; dose-response (fig. 3A); peptides; animal info (Sprague-Dawley, male, 275-300g, chronically decerebrate); endocrinology.

P8685 Davidson,C., Chen,Q., Zhang,X., Xiong,X.Y., Lazarus,C., Lee,T.H., Ellinwood,E.H. Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine. European Journal of Pharmacology 2007; 573(-1-3-):100-110. >>> Methamphetamine; Saline; SC; Rat; 2ML1; 7 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; dose-response (fig. 1, p. 104); stress/adverse reaction: (see pg. 101) "Animals that did show self-injuries were treated with an oral antibiotic (Sulfatrim) in their drinking water and, if this was ineffective they were humanely destroyed" p. 101; good methods p. 102; half-life (p. 101) "short"; post op. care (Apo-sulfatrim); animal info (male, Sprague-Dawley, 360-400g); "The pump was removed after 7 days... no animal had greater than 0.2 ml methamphetamine (ie 10% initial volume) remaining" (p. 102).

P8683 Garcia-San Frutos,M., Fernandez-Agullo,T., De Solis,A.J., Andres,A., Arribas,C., Carrascosa,J.M., Ros,M. Impaired central insulin response in aged Wistar rats: Role of adiposity. Endocrinology 2007; 148(-11-):5238-5247. >>> Insulin, human; PBS; CSF/CNS; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; dose-response (fig. 1, p. 5241); peptides; animal info (Wistar, 3, 8, 24 month, male); endocrinology.

P8682 Sferruzzi-Perri,A.N., Owens,J.A., Standen,P., Taylor,R.L., Robinson,J.S., Roberts,C.T. Early pregnancy maternal endocrine insulin-like growth factor I programs the placenta for increased functional capacity throughout gestation. Endocrinology 2007; 148(-9-):4362-4370. >>> Insulin-like growth factor I; insulin-like growth factor II, recomb. human; Acetic acid; SC; Guinea-pig; 2002; 18 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; animal info (pregnant, female, 500g, 3-4 weeks); endocrinology.

P8678 Gallardo,N., Bonzon-Kulichenko,E., Fernandez-Agullo,T., Molto,E., Gomez-Alonso,S., Blanco,P., Carrascosa,J.M., Ros,M., Andres,A. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 2007; 148(-12-):5604-5610. >>> Leptin; PBS; CSF/CNS; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; peptides; animal info (3 months old, Wistar, male); endocrinology.

P8674 Yang,J., Dhawan,V., Morrish,D.W., Kaufman,S. Bimodal effects of chronically administered neurokinin B (NKB) on in vivo and in vitro cardiovascular responses in female rats. REGULATORY PEPTIDES 2007; 143(-1-3-):136-142. >>> Neurokinin B; DMSO; water; IV (inferior vena cava); Rat; 2001D; 2ML1; 5 days, 22 hours; Controls received mp w/ vehicle; functionality of mp verified by blood pressure; dose-response (p. 138); cardiovascular; peptides; multiple pumps per animal (3); animal info (female, Long Evans, 250-300g); neuropeptide; silastic cannula; telemetry implanted IP; 10% DMSO used; (3) 2001D pumps used to achieve a higher concentration for 22 hours.

P8668 Almon,R.R., DuBois,D.C., Yao,Z.L., Hoffman,E.P., Ghimbovschi,S., Jusko,W.J. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. PHYSIOLOGICAL GENOMICS 2007; 30(-3-):282-299. >>> Methylprednisolone; Saline; SC; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by MPL plasma levels via HPLC; replacement therapy (adrenalectomy); dose-response (fig. 7, p. 287); comparison of injections vs. mp; stress/adverse reaction: (see pg. 296) muscle atrophy; tolerance; animal info (male, Wistar, 339g); "By 6 h, MPL concentrations reach a stable steady state that is maintained throughout the 7-day infusion period. In contrast, single MPL doses... result in drug concentrations that dissipate in a biexponential fashion and fall below the level of dection by 7 h." p. 288.

P8658 Rai,K.S., Hattiangady,B., Shetty,A.K. Enhanced production and dendritic growth of new dentate granule cells in the middle-aged hippocampus following intracerebroventricular FGF-2 infusions. European Journal of Neuroscience 2007; 26(-7-):1765-1779. >>> Fibroblast growth factor-2; CSF, artificial; CSF/CNS; Rat; 2002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; good methods (p. 1766-1767); ALZET brain infusion kit used; cyanoacrylate adhesive; post op. care (tetracycline); animal info (male, F344, 12 months).

P8655 Gemma,C., Bachstetter,A.D., Cole,M.J., Fister,M., Hudson,C., Bickford,P.C. Blockade of caspase-1 increases neurogenesis in the aged hippocampus. European Journal of Neuroscience 2007; 26(-10-):2795-2803. >>> YVAD-CMK, Ac-; DMSO; saline; CSF/CNS; Rat; 2004; 28 days; Controls received mp w/ vehicle; functionality of mp verified by mp weight (not suggested by manufacturer); enzyme inhibitor (caspase-1); animal info (male, Fischer 344; 4 and 22 months old); 0.6% DMSO.

P8647 Tohyama,Y., Mueck-Seler,D., Diksic,M. Acute fiesinoxan treatment produces a different effect on rat brain serotonin synthesis than chronic treatment: An alpha-methyl-L-tryptophan autoradiographic study. NEUROCHEMISTRY INTERNATIONAL 2007; 51(-8-):486-495. >>> Flesinoxan hydrochloride; Saline; SC; CSF/CNS; Rat; 2ML2; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by residual volume; animal info (male, Sprague-Dawley, 170-210g).

P8624 Guan,Y., Zhang,Y.H., Wu,J., Qi,Z.H., Yang,G.R., Dou,D., Gao,Y.S., Chen,L.H., Zhang,X.Y., Davis,L.S., Wei,M.F., Fan,X.F., Carmosino,M., Hao,C., Imig,J.D., Breyer,R.M., Breyer,M.D. Anti hypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. Journal of Clinical Investigation 2007; 117(-9-):2496-2505. >>> Angiotensin II; Saline, sterile; SC; Mice; 2004; 4 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; comparison of IV acute infusion; cardiovascular; peptides; animal info (male, N10 129S6/SvEvTac Ep1 t/t, -/-).

P8619 Stoller,D., Kakkar,R., Smelley,M., Chalupsk,K., Earley,J.U., Shi,N.Q., Makielski,J.C., McNally,E.M. Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress. Journal of Molecular and Cellular Cardiology 2007; 43(-4-):445-454. >>> Nifedipine; DMSO; IP; Mice; 1002; >7 days; Controls received no treatment; functionality of mp verified by mp examination; cardiovascular; ischemia (cardiac); animal info (male, SUR2 -/-, wt FVB, 12-18 weeks old).

P8616 LI,X.C., Navar,L.G., SHAO,Y., Zhuo,J.L. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice. American journal of physiology.Renal physiology 2007; 293(--):F586-F593. >>> Angiotensin II; IP; Mice; 2002; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; peptides; animal info (male, C57BL/6J, 25 grams, 10 weeks old).

P8615 Coles,B., Fielding,C.A., Rose-John,S., Scheller,J., Jones,S.A., O'Donnell,V.B. Classic Interleukin-6 Receptor Signaling and Interleukin-6 trans-Signaling Differentially Control Angiotensin II-Dependent Hypertension, Cardiac Signal Transducer and Activator of Transcription-3 Activation, and Vascular Hypertrophy in Vivo. American Journal of Pathology 2007; 171(-1-):315-325. >>> Angiotensin II; Saline; SC; Mice; 1002; 7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; no stress (see pg. 317); cardiovascular; peptides; animal info (male, C57BL/6J wt or IL-6 -/-, 25-30 grams, 10-12 weeks old).

P8611 Itoh,T., Obata,H., Murakami,S., Hamada,K., Kangawa,K., Kimura,H., Nagaya,N. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. American Journal of Physiology- Lung Cellular and Molecular Physiology 2007; 293(-2-):L446-L452. >>> Adrenomedullin, recomb. human; Saline; IV (jugular); Rat; 2001D; 8,20 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; no stress (see pg. L447); peptides; animal info (male, Sprague-Dawley, 180-200 grams, LPS-induced lung injury); "The animals showed no signs of distress with this procedure." (p. L447).

P8610 Dietrich,T., Onderka,J., Bock,F., Kruse,F.E., Vossmeyer,D., Stragies,R., Zahn,G., Cursiefen,C. Inhibition of Inflammatory Lymphangiogenesis by Integrin alpha 5 Blockade. American Journal of Pathology 2007; 171(-1-):361-372. >>> JSM6427; JSM6424; SC; Mice; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by mp and plasma levels analysis; dose-response (p. 368); pumps replaced after one week; half-life (p. 363) "rapid;" cardiovascular; immunology; animal info (BALB/C, 6 weeks old, suture-induced inflammatory corneal neovascularization); integrin a5B1 and avB3 antagonists; angiogenesis; lymphangiogenesis.

P8608 Very,N.M., Sheridan,M.A. Somatostatin regulates hepatic growth hormone sensitivity by internalizing growth hormone receptors and by decreasing transcription of growth hormone receptor mRNAs. American Journal of Physiology- Regulatory, Integrative and Comparative Physiology 2007; 292(-5-):R1956-R1962. >>> Somatostatin-14-I; Saline; IP; Fish (trout); 15 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; peptides; animal info (male, female, juvenile, rainbow trout, 58 grams).

P8605 Ozawa,Y., Kobori,H. Crucial role of Rho-nuclear factor-kappa B axis in angiotensin II-induced renal injury. American Journal of Physiology- Renal Physiology 2007; 293(-1-):F100-F109. >>> Angiotensin II; SC; Rat; 12 days; Controls received sham operation; functionality of mp verified by systolic blood pressure; cardiovascular; animal info (male, Sprague-Dawley, 250 grams).

P8604 Ortiz,R.M., Graciano,M.L., Seth,D., Awayda,M.S., Navar,L.G. Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension. American Journal of Physiology- Renal Physiology 2007; 293(-1-):F139-F147. >>> Angiotensin II; Rat; 2004; 28 days; Controls received sham operation; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 200-225 grams); radiotelemetry devices surgically implanted 5 days before mp.

P8599 Stocker,C.J., Wargent,E., O'Dowd,J., Cornick,C., Speakman,J.R., Arch,J.R.S., Cawthorne,M.A. Prevention of diet-induced obesity and impaired glucose tolerance in rats following administration of leptin to their mothers. American Journal of Physiology- Regulatory, Integrative and Comparative Physiology 2007; 292(-5-):R1810-R1818. >>> Leptin, rat; Saline, physiological; SC; Rat (pregnant); 28 days; Controls received mp w/ vehicle; functionality of mp verified by plasma leptin concentration; teratology; peptides; animal info (female, Wistar, 200-225 grams, gestational day 14).

P8589 Franco,M., Martinez,F., Quiroz,Y., Galicia,O., Bautista,R., Johnson,R.J., Rodriguez-Iturbe,B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 2007/7; 293(-1-):R251-R256. >>> Angiotensin II; SC; Rat; 2002; 2 weeks; Functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 340-360 grams); nephrology.

P8585 Fava,G., Ueno,Y., Glaser,S., Francis,H., Demorrow,S., Marucci,L., Marzioni,M., Benedetti,A., Venter,J., Vaculin,B., Vaculin,S., Alpini,G. Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP3/Ca2+-dependent downregulation of SRC/ERK1/2. Am J Physiol Cell Physiol 2007/4; 292(-4-):C1467-C1475. >>> Triiodothyronine, 2,3',5 L-; NaOH; BSA; IP; Rat; 1 week; Controls received mp w/ vehicle; functionality of mp verified by serum T3 levels; animal info (male, Fisher 344, 150-175g, bile duct ligation).

P8583 Boesen,E.I., Pollock,D.M. Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice. Am J Physiol Heart Circ.Physiol 2007/9; 293(-3-):H1745-H1749. >>> Interleukin-6, recomb. mouse; PBS; BSA; SC; Mice; 1002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by plasma IL-6 concentrations; peptides; cardiovascular; animal info (C57BL/6, male).

P8582 Garg,P., Martin,C.F., Elms,S.C., Gordon,F.J., Wall,S.M., Garland,C.J., Sutliff,R.L., O'Neill,W.C. Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. American Journal of Physiology- Heart and Circulatory Physiology 2007; 292(-5-):H2100-H2105. >>> Norepinephrine; SC; Rat; 2001; 7 days; Functionality of mp verified by mean arterial blood pressure; cardiovascular; animal info (male, Sprague-Dawley, 360 grams).

P8577 Grossmann,C., Krug,A.W., Freudinger,R., Mildenberger,S., Voelker,K., Gekle,M. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am.J.Physiol Endocrinol.Metab 2007/6; 292(-6-):E1790-E1800. >>> Aldosterone; dexamethasone; DMSO; Rat; 2ML1; 6 days; Controls received mp w/ vehicle; functionality of mp verified by plasma concentrations; replacement therapy (adrenalectomy); animal info (male, Munich-Wistar, 200-250 grams); endocrinology.

P8574 Cunningham,M.G., Ames,H.M., Donalds,R.A., Benes,F.M. Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents. J Neurosci Methods 2007; 167(-2-):213-220. >>> Saline, sterile; dye, fast green; Saline; CSF/CNS (striatum); Rat; 1002; 1,2,4,5 days; 12 hours; Functionality of mp verified by residual volume; good methods (p. 214-217); animal info (male, Sprague-Dawley, 400-450 grams); comparison of standard 28 gauge delivery cannula with 50 micron microcannula; one-half of mp coated with paraffin to reduce flow rate; borosilicate tubing used in microcannula; mp primed 12 hours in 37 C saline; "this technique allows small substructures to be targeted and reduces trauma in the area of intereset." (p. 213).

P8573 Hilgers,R.H.P., Webb,R.C. Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2007; 292(-5-):H2275-H2284. >>> Angiotensin II; SC; Rat; 1,14 days; Controls received mp w/ saline; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (Sprague-Dawley, 225-250 grams); "We have chosen the experimental model of chronic Ang II infusion using an osmotic minipump...this model of hypertension enables us to study the effect of a sudden drastic rise in blood pressure at adult age on changes in the expression of SKCa and IKCa channels in small resistance sized arteries." (p. H2279).

P8567 Zhang,J., Tokui,Y., Yamagata,K., Kozawa,J., Sayama,K., Iwahashi,H., Okita,K., Miuchi,M., Konya,H., Hamaguchi,T., Namba,M., Shimomura,I., Miyagawa,J.I. Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia 2007; 50(-9-):1900-1909. >>> Glucagon-like peptide-1; Acetic acid buffer, 5%; SC; Mice; 2004; 4 or 8 weeks; Controls received mp w/ saline; functionality of mp verified by GLP-1 plasma levels; long-term study; pumps replaced after 4 weeks; animal info (female, NOD mice, 8 weeks old); diabetes; "plasma concentrations of active GLP-1...after pump implantation were significantly elevated and about 1.5 fold higher than before the pump implantation. We therefore considered this delivery system to be appropriate for this experiment." (p. 1903).

P8555 Adamek,A., Hu,K., Bayer,B., Wagner,H., Ertl,G., Bauersachs,J., Frantz,S. High dose aspirin and left ventricular remodeling after myocardial infarction. Basic Research In Cardiology 2007; 102(-4-):334-340. >>> Acetylsalicylic acid, lysine; Saline; SC; Mice; 2002; 4 weeks; Controls received mp w/ placebo; functionality of mp verified by serum salicylate concentrations; pumps replaced after 2 weeks; cardiovascular; ischemia (cardiac); animal info (female, C57BL/6, 8-12 weeks old, 20-25 grams); MI induced by coronary artery ligation.

P8545 Roth,J.D., Hughes,H., Coffey,T., Maier,H., Trevaskis,J.L., Anderson,C.M. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2007; 293(-4-):E1112-E1117. >>> Amylin; Water; DMSO; SC; Rat; 7,17 days; Controls received mp w/ vehicle; functionality of mp verified by plasma amylin levels; peptides; animal info (female, Sprague-Dawley, 316 grams, male, 545 grams); 50% DMSO used.

P8537 Kim,Y.H., Pech,V., Spencer,K.B., Beierwaltes,W.H., Everett,L.A., Green,E.D., Shin,W., Verlander,J.W., Sutliff,R.L., Wall,S.M. Reduced ENaC protein abundance contributes to the lower blood pressure observed in pendrin-null mice. American Journal of Physiology-Renal Physiology 2007; 293(-4-):F1314-F1324. >>> Aldosterone; Saline; DMSO; SC; Mice; 7 days; Controls received mp w/ vehicle; functionality of mp verified by serum aldosterone levels; 2.4% DMSO used.

P8533 Morrey,J.D., Siddharthan,V., Olsen,A.L., Wang,H., Julander,J.G., Hall,J.O., Li,H., Nordstrom,J.L., Koenig,S., Johnson,S., Diamond,M.S. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Antimicrob.Agents Chemother. 2007/7; 51(-7-):2396-2402. >>> Antibody, monoclonal, hE16; CSF/CNS (pons); Hamster; 2001D; 24 hours; Controls received aCSF; functionality of mp verified by previous study with dye; comparison of IP injections vs. mp; post op. care (buprenorphine); animal info (female, Syrian golden, >7 weeks old); cannula placement confirmed with dye; E16 is anti-domain III of the West Nile Virus envelope protein.

P8524 Jiang,F., Jones,G.T., Dusting,G.J. Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice. British Journal of Pharmacology 2007; 152(-6-):880-890. >>> Angiotensin II; losartan; SC; Mice; 4 weeks; Controls received mp w/ saline; functionality of mp verified by systolic blood pressure; no stress (see pg. 882); cardiovascular; peptides; animal info (male, ApoE -/-, 50-60 weeks old, 30 grams).

P8518 Lever,I.J., Pheby,T.M., Rice,A.S.C. Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity. British Journal of Pharmacology 2007; 151(-2-):292-302. >>> WIN 55,212-2 mesylate salt; SR141716A; SR144528; Saline; tween 20; albumin, rat serum; DMSO; CSF/CNS (sciatic nerve); Rat; 2001; 6, 7 days; Controls received mp w/ vehicle; functionality of mp verified after removal, as well as mp/catheter connection, catheter patency and position; dose-response (fig. 3); animal info (male, Wistar, 250-300 g, partial ligation injury); 4% DMSO; 14.5 % DMSO.

P8480 Levy,A., Cohen,G., Gilat,E., Kapon,J., Dachir,S., Abraham,S., Herskovitz,M., Teitelbaum,Z., Raveh,L. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. Archives of Toxicology 2007; 81(-5-):353-359. >>> Caramiphen; SC; Dog; 2001; 2ML1; 48 hours; Functionality of mp verified by plasma levels; toxicology; pharmacokinetics.

P8477 Mack,C., Wilson,J., Athanacio,J., Reynolds,J., Laugero,K., Guss,S., Vu,C., Roth,J., Parkes,D. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007; 293(-5-):R1855-R1863. >>> Amylin; DMSO; SC; Rat; 2ML4; 4,8,11 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma amylin concentrations; dose-response (fig 1); comparison of IP injections vs. mp; long-term study; pumps replaced every 4 weeks; half-life (p. R1861) "short;" peptides; animal info (male, Sprague-Dawley, Levin DIOP); 50% DMSO used; endocrinology; "Due to its short half-life, amylin was administered via subcutaneous infusion as a proof of concept for its potential use as an antiobesity agent." (p. R1861).

P8463 Shen,X.Z., Li,P., Weiss,D., Fuchs,S., Xiao,H.D., Adams,J.A., Williams,I.R., Capecchi,M.R., Taylor,W.R., Bernstein,K.E. Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. American Journal of Pathology 2007; 170(-6-):2122-2134. >>> Captopril; losartan; SC; Mice; 2 weeks; Functionality of mp verified by systolic blood pressure; enzyme inhibitor (ACE); cancer (melanoma); immunology; animal info (C56BL/6, wt, ACE 10/10, 8wks old).

P8451 Ideura,H., Hiromura,K., Hiramatsu,N., Shigehara,T., Takeuchi,S., Tomioka,M., Sakairi,T., Yamashita,S., Maeshima,A., Kaneko,Y., Kuroiwa,T., Kopp,J.B., Nojima,Y. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. American Journal of Physiology-Renal Physiology 2007; 293(-4-):F1214-F1221. >>> Angiotensin II; norepinephrine; SC; Mice (transgenic); 2004; 16 days; Functionality of mp verified by blood pressure; cardiovascular; peptides; animal info (FVB/N Podocin/rt TA tg, 7-8 wks old, 20-25g) nephrology.

P8450 Jackman,K.A., Woodman,O.L., Chrissobolis,S., Sobey,C.G. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Research 2007; 1141(--):99-107. >>> Angiotensin II; Acetic acid; SC; Rat; 14 days; Functionality of mp verified by mean arterial pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 260-440g).

P8436 Rabbani,Z.N., Batinic-Haberle,I., Anscher,M.S., Huang,J., Day,B.J., Alexander,E., Dewhirst,M.W., Vujaskovic,Z. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 2007; 67(-2-):573-580. >>> AEOL 10150; SC; Rat; 2002; 10 weeks; 8 days; Controls received mp w/ vehicle; functionality of mp verified by plasma AEOL 10150 concentrations; dose-response (fig. 4); long-term study; pumps replaced every 2 weeks; half-life (p. 574), short; cancer; animal info (female, Fisher-344, 150-170 grams); "Osmotic mini-pumps provided consistent and dose-dependent delivery of AEOL 10150," "a continuous availability of antioxidant via osmotic infusion pumps throughout the study." (p. 575).

P8422 Lavoie,N., Peralta,MR III, Chiasson,M., Lafortune,K., Pellegrini,L., Seress,L., Toth,K. Extracellular chelation of zinc does not affect hippocampal excitability and seizure-induced cell death in rats. JOURNAL OF PHYSIOLOGY-LONDON 2007; 578(-1-):275-289. >>> Tricine; EDTA, copper; EDTA, zinc; EDPA; EDTA, calcium; Saline; cresyl violet; CSF/CNS; Rat; 2001D; 12 hours; Controls received mp w/ vehicle; functionality of mp verified by residual volume; brain tissue distribution; animal info (male, Sprague-Dawley, >35 days old); cresyl violet used to verify injection site.

P8418 Kang,K.T., Sullivan,J.C., Sasser,J.M., Imig,J.D., Pollock,J.S. Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension 2007; 49(-4-):893-901. >>> Angiotensin II; SC; Rat; 2 weeks; Functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 220-250g.).

P8399 Perry,T., Holloway,H.W., Weerasuriya,A., Mouton,P.R., Duffy,K., Mattison,J.A., Greig,N.H. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Experimental Neurology 2007; 203(-2-):293-301. >>> Glucagon-like peptide-1, (7-36)-amide; exendin-4; exendin (9-39); peptide, inactive; SC; Rat; 14 days; Controls received mp w/ scrambled, inactive, 30aa peptide; functionality of mp verified by plasma GLP-1 levels; dose-response (fig. 3); half-life (pg. 293) 1.5 min. in rodents (GLP-1), 120 min. in rodents (Ex4); peptides; multiple pumps per animal (2); animal info (male, Sprague-Dawley, 300-350g.).

P8392 Yang,L., Zou,X.J., Liang,Q.S., Chen,H., Feng,J., Yan,L., Wang,Z.H., Zhou,D.X., Li,S.S., Ya,S.L., Zheng,Z. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. EXPERIMENTAL AND MOLECULAR MEDICINE 2007; 39(-1-):65-73. >>> Angiotensin II; Saline; SC; Rat; 3 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; animal info (Wistar, 200-300g.).

P8390 Johnston,R.A., Theman,T.A., Terry,R.D., Williams,E.S., Shore,S.A. Pulmonary responses to acute ozone exposure in fasted mice: effect of leptin administration. Journal of Applied Physiology 2007; 102(-1-):149-156. >>> Leptin, recomb. mouse; PBS; HCR; NaOH; SC; Mice; 1007D; 7 days; Controls received mp w/ vehicle; functionality of mp verified by serum leptin concentration; peptides; post op. care (buprenorphine hydrochloride); animal info (male, C57BL/6J, 8 wks old).

P8385 Sferruzzi-Perri,A.N., Owens,J.A., Standen,P., Taylor,R.L., Heinemann,G.K., Robinson,J.S., Roberts,C.T. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2007; 292(-3-):E668-E676. >>> Insulin-like growth factor I; Insulin-like growth factor II, recomb. human; Acetic acid; SC; Guinea-Pig (pregnant); 2002; 18 days; Controls received mp w/ vehicle; functionality of mp verified by IGF-I/II maternal circulation levels; peptides; animal info (female, pregnant, 500g., 3-4 months old, gestation days 20-38).

P8380 Leopold,J.A., Dam,A., Maron,B.A., Scribner,A.W., Liao,R., Handy,D.E., Stanton,R.C., Pitt,B., Loscalzo,J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nature Medicine 2007; 13(-2-):189-197. >>> Aldosterone; Mice; 1002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by plasma aldosterone levels and systolic BP; cardiovascular; animal info (male, C3H wt; G6PD-deficient, 12-16 wks old).

P8370 Lopez-Lopez,C., Dietrich,M.O., Metzger,F., Loetscher,H., Torres-Aleman,I. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease. Journal of Neuroscience 2007; 27(-4-):824-831. >>> Insulin-like growth factor I, recomb. human; SC; Mice; 1002; ; Controls received mp w/ saline; functionality of mp verified by serum IGF-I levels; peptides; animal info (C57BL/6J, APP/PS2, 6 month old); neurodegenerative (Alzheimer's disease).

P8367 Wranning,C.A., El-Akouri,R.R., Groth,K., Moelne,J., Parra,A.K., Braennstroem,M. Rejection of the transplanted uterus is suppressed by cyclosporine A in a semi-allogeneic mouse model. Human Reproduction 2007; 22(-2-):372-379. >>> Cyclosporin A; Propylene glycol; SC; Mice; 1007D; 7-10 days; Controls received mp w/ vehicle, or no treatment; functionality of mp verified by serum CyA levels; dose-response (Table 1); immunology; post op.care (buprenorphin, carprofen, cefuroxine); animal info (female, C57BL/6, B6CBAF1, 6-8 wks old, uterine transplant).

P8356 Nieves-Cintron,M., Amberg,G.C., Nichols,C.B., Molkentin,J.D., Santana,L.F. Activation of NFATc3 down-regulates the beta 1subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension. Journal of Biological Chemistry 2007; 282(-5-):3231-3240. >>> Angiotensin II; Saline; SC; Mice; 5-7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic and diastolic BP; cardiovascular; peptides; animal info (BALB/C).

P8354 Burke,S.L., Head,G.A., Lambert,G.W., Evans,R.G. Renal sympathetic neuroeffector function in renovascular and angiotensin II-dependent hypertension in rabbits. Hypertension 2007; 49(-4-):932-938. >>> Angiotensin II; SC; Rabbit; 2ML4; 4-6 weeks; Controls received sham surgery; functionality of mp verified by blood pressure; pumps replaced after 22 days; cardiovascular; peptides; animal info (male, New Zealand white, 2.8 kg).

P8347 Virdis,A., Colucci,R., Fornai,M., Duranti,E., Giannarelli,C., Bernardini,N., Segnani,C., Ippolito,C., Antonioli,L., Blandizzi,C., Taddei,S., Salvetti,A., Del Tacca,M. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2007; 49(-3-):679-686. >>> Angiotensin II; Saline, physiological; SC; Mice; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; no stress (see pg. 682); cardiovascular; peptides; animal info (male, DBA/1N, 12-14 weeks old, 25 grams).

P8344 Bondi,C.O., Barrera,G., Lapiz,M.D.S., Bedard,T., Mahan,A., Morilak,D.A. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY&BIOLOGICAL PSYCHIATRY 2007; 31(-2-):482-495. >>> Desipramine; Ethanol; IP; Rat; 2ML2; 2ML4; 7, 14, 21 days; Controls received mp w/ vehicle; functionality of mp verified by plasma DMI levels; comparison of IP injections vs. mp; post op. care (penicillin G); animal info (male, Sprague-Dawley, 200-250 grams); 10% ETOH.

P8343 Bone,W., Walden,C.M., Fritsch,M., Voigtmann,U., Leifke,E., Gottwald,U., Boomkamp,S., Platt,F.M., van der Spoel,A.C. The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study. Reproductive Biology and Endocrinology 2007; 5(--):U1-U13. >>> Miglustat; SC; Mice; 2004; 7 weeks; Functionality of mp verified by serum agent levels; comparison of oral vs. mp; long-term study; enzyme inhibitor (ceramide glucosyltransferase); animal info (male, C57BL/6J, BALB/C, FVB/N, 6 weeks old); reproductive endocrinology.

P8341 Bruijnzeel,A.W., Marcinkiewcz,C., Isaac,S., Booth,M.M., Dennis,D.M., Gold,M.S. The effects of buprenorphine on fentanyl withdrawal in rats. Psychopharmacology 2007; 191(-4-):931-941. >>> Fentanyl citrate salt; Saline, sterile; SC; Rat; 2ML2; 2ML4; 14, 28 days; Controls received mp w/ vehicle; functionality of mp verified by plasma fentanyl concentrations; tolerance; dependence; animal info (male, Wistar, 300-350 grams).

P8314 Short,K.R., Nygren,J., Nair,K.S. Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2007; 292(-2-):E642-E647. >>> Triiodothyronine; Saline; Na2CO3; NaOH; BSA; SC; Rat; 14 days; Controls received mp w/ vehicle; functionality of mp verified by serum T3 levels; animal info (male, Sprague-Dawley, 325-350g.); endocrinology.

P8281 Lee,M.C., Bier,A.D., Nickisch,F., Eberson,C.P., Ehrlich,M.G., Chen,Q. Epiphysiodesis with infusion of stromal cell-derived factor-1 in rabbit growth plates. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME 2007; 89A(-1-):102-113. >>> Stromal cell-derived factor-1a, recomb. human; dye, methylene blue; PBS; hypaque; Bone (tibial physis); Rabbit; 2001D; 2004; 2,4 weeks; 24 hours; Controls received mp w/ vehicle and control leg w/ no treatment; functionality of mp verified by methylene blue study, hypaque; good methods (p. 103-105); peptides; post op. care (buprenorphine); animal info (New Zealand white, 6 weeks old, 2.5 kg); catheter with 16 fenestrations used; 30% hypaque, which "served as a radio-opaque marker of pump reservoir level."; "A continuous, implantable, direct delivery system offers a practical model for studying the local effects of various reagents on the physis and a therapeutic model by which agents for use in epiphysiodesis may be evaluated." (p. 110).

P8273 Yao,Y.Y., Yin,H., Shen,B., Chao,L., Chao,J. Tissue kallikrein infusion prevents cardiornyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. REGULATORY PEPTIDES 2007; 140(-1-2-):12-20. >>> Kallikrein, rat tissue; icatibant; Saline; SC; Rat; 7 days; Controls received mp w/ vehicle; functionality of mp verified by plasma TK levels; comparison of intramyocardial injections vs. mp; cardiovascular; peptides; ischemia (cardiac); animal info (male, Wistar, 250-280 g, left coronary artery ligation); "The advantage of kallikrein protein infusion via osmotic minipumps is to provide a stable supply of the therapeutic protein or peptide without potential side effects." (p. 18); "Kallikrein protein infusion has advantages over adenovirus-mediated delivery." (p. 18).

P8266 Urushitani,M., bou Ezzi,S., Julien,J.P. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2007; 104(-7-):2495-2500. >>> Antibody, mouse anti hSOD1; antibody, rabbit polyclonal anit-hSOD1-FITC; Saline; CSF/CNS; Mice; 2004; 16, 28 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; stability verified by Western Blot w/ residual volume AB after 18 days infusion; brain tissue distribution; animal info (G93A SOD1, 85 days old); neurodgenerative (ALS).

P8257 Elmarakby,A.A., Williams,J.M., Imig,J.D., Pollock,J.S., Pollock,D.M. Synergistic actions of enalapril and ternpol during chronic angiotensin II-induced hypertension. VASCULAR PHARMACOLOGY 2007; 46(-2-):144-151. >>> Angiotensin II; icatibant; SC; Rat; 2002; 14 days; Controls received no treatment; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; multiple pumps per per animal (2); animal info (male, Sprague-Dawley, 200-250g.).

P8248 Nielsen,J., Kwon,T.H., Frokiaer,J., Knepper,M.A., Nielsen,S. Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade. American Journal of Physiology-Renal Physiology 2007; 292(-1-):F382-F394. >>> Aldosterone; Saline, sterile; DMSO; SC; Rat; 2002; 7, 10 days; Controls received mp w/ vehicle; functionality of mp verified by plasma aldosterone levels; dose-response (pg F383); no stress (see pg F384); post op. care (bupivacaine); animal info (male, Sprague-Dawley, 190-210g); 25% DMSO.

P8144 Gu,L., Zhu,Y.J., Yang,X., Guo,Z.J., Xu,W.B., Tian,X.L. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation. Acta Pharmacologica Sinica 2007; 28(-3-):382-391. >>> Bleomycin; Saline; SC; Mice; 1007D; 7 days; Controls received mp w/ vehicle; functionality of mp verified by examination; no stress (see p.384); animal info (Smad 3 -/- or wt, 8-10 wks old, 17g. 27g.).

P8117 Gould,G.G., Javors,M.A., Frazer,A. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biological Psychiatry 2007; 61(-2-):210-215. >>> Duloxetine; desipramine; paroxetine; Ethanol; water; SC; Rat; 2ML4; 21 days; Controls received mp w/ vehicle; functionality of mp verified by serum agent concentrations; dose-response (p.211); animal info (male, Sprague-Dawley, 125-150g).

P8097 Fujita,M., Imaizumi,M., D'Sa,C., Zoghbi,S.S., Crescenzo,M.S., Hong,J.S., Musachio,J.L., Gee,A.D., Seidel,J., Green,M.V., Pike,V.W., Duman,R.S., Innis,R.B. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration. Synapse 2007; 61(-2-):78-86. >>> Imipramine; Saline; SC; Rat; 20, 27 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; animal info (male, Sprague-Dawley, 268-345g.); Positron emission tomography (PET); "To avoid injection-induced stress and fluctuations of imipramine and the metabolite levels, we administered imipramine using osmotic minipump" (p.84).

P8086 de Borst,M.H., van Timmeren,M.M., Vaidya,V.S., de Boer,R.A., van Dalen,M.B.A., Kramer,A.B., Schuurs,T.A., Bonventre,J.V., Navis,G., van Goor,H. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. American Journal of Physiology-Renal Physiology 2007; 292(-1-):F313-F320. >>> Candesartan; SB-239063; Saline; water; PEG 400; NaHC03; DMSO; SC; Rat; 2004; 2ML4; 4 weeks; Controls received no treatment; functionality of mp verified by residual volume; enzyme inhibitor (p38 MAP Kinase); animal info (male, TGR (mRen2) 27, 7 wks old, male, Sprague-Dawley); 0.1% DMSO.

P7941 Cooper,J.D., Heppert,K.E., Davies,M.I., Lunte,S.M. Evaluation of an osmotic pump for microdialysis sampling in an awake and untethered rat. J.Neurosci.Methods 2007/3/15; 160(-2-):269-275. >>> Ringer's solution, lactated; CSF/CNS (striatum); Rat; 2ML1; 3-5 days; Functionality of mp verified by collection rate and volume; comparison of microdialysis syringe pump vs. mp; no stress; good methods; animal info (male, Sprague-Dawley, 350-450 grams); mp used in novel microdialysis sampling technique; "...microdialysis probe did not significantly alter mp flow rate or precision;" allows microdialysis in untethered animals; "the osmotic pump can be an invaluable improvement over the syringe pump.".

P8407 Pradhan,A., Umezu,M., Fukagawa,M. Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. American Journal of Nephrology 2006; 26(-6-):552-561. >>> Angiotensin II; Ringer's solution, lactated; SC; Rat; 2002; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 200-250g.); Nephrology.

P8401 Masuyama,H., Tsuruda,T., Kato,J., Imamura,T., Asada,Y., Stasch,J.P., Kitamura,K., Eto,T. Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats. Hypertension 2006; 48(-5-):972-978. >>> Angiotensin II; SC; Rat; 2002; 14 days; Controls received no treatment; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Wistar, 8 wks old, 200-250g).

P8394 Earle,S.A., El-Haddad,A., Patel,M.B., Ruiz,P., Pham,S.M., Majetschak,M. Prolongation of skin graft survival by exogenous ubiquitin. Transplantation 2006; 82(-11-):1544-1546. >>> Ubiquitin; albumin; Saline, normal; IP; Mice; 2002; 5,14 days; Controls received mp w/ vehicle, or albumin or no treatment; functionality of mp verified by serum ubiquitin levles; dose-response (fig. 1); no stress (see pg. 1546); immunology; peptides; animal info ( C3H/HEJ, DBA2, 22g., skin grafts); "Ubiquitin administration was well tolerated and body weight was similar in both groups" (pg. 1546).

P8369 Peterson,J.M., Feeback,K.D., Baas,J.H., Pizza,F.X. Tumor necrosis factor-alpha promotes the accumulation of neutrophils and macrophages in skeletal muscle. Journal of Applied Physiology 2006; 101(-5-):1394-1399. >>> Tumor necrosis factor-a, recomb. mouse; Saline, physiological; albumin, mouse serum; SC; Mice; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; no stress (see pg. 1396); peptides; animal info (male, C57BL/6J, 27-30g.).

P8340 Sarr,M., Chataigneau,M., Martins,S., Schott,C., El Bedoui,J., Oak,M.H., Muller,B., Chataigneau,T., Schini-Kerth,V.B. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase. Cardiovascular Research 2006; 71(-4-):794-802. >>> Angiotensin II; Saline; acetic acid; SC; Rat; 2004; 14 days; Controls received sham operation; functionality of mp verified by systolic blood pressure; cardiovascular; animal info (male, Wistar, 12-15 weeks old).

P8339 Schertzer,J.D., Lynch,G.S. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Therapy 2006; 13(-23-):1657-1664. >>> Insulin-like growth factor I; SC; Mice; 1002; 3, 10, 14 days; Controls received non-coding plasmid; functionality of mp verified by residual volume; comparison of gene transfer vs. mp; peptides; animal info (male, C57BL10, 12-14 weeks old, myotoxic tibialis anterior muscle injury).

P8317 Omata,M., Taniguchi,H., Koya,D., Kanasaki,K., Sho,R., Kato,Y., Kojima,R., Haneda,M., Inomata,N. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephiritis. Journal of the American Society of Nephrology 2006; 17(-3-):674-685. >>> Peptide, Ac-SDKP; Saline; acetic acid; SC; Rat; 2ML4; 4 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma Ac-SDKP levels; replacement therapy (anti-GBM Nephritis); peptides; animal info (male, Wistar-Kyoto, 7 wks old).

P8313 Shore,S.A., Terry,R.D., Flynt,L., Xu,A.M., Hug,C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. Journal of Allergy and Clinical Immunology 2006; 118(-2-):389-395. >>> Adiponectin, recomb. mouse; Saline, Tris-buffered; SC; Mice; 1007D; 6 days; Controls received mp w/ vehicle; functionality of mp verified by serum adiponectin levels; no stress (see pg. 391); peptides; post op. care (Buprenorphine hydrochloride); animal info (male, female, BALB/cJ, 4 wks old).

P8296 Sykes,J.M., Ramsay,E.C., Schumacher,J., Daniel,G.B., Cox,S., Papich,M. Evaluation of an implanted osmotic pump for delivery of amikacin to corn snakes (Elaphe guttata guttata). JOURNAL OF ZOO AND WILDLIFE MEDICINE 2006; 37(-3-):373-380. >>> Amikacin; Saline, sterile; Intracoelomic; Snake (corn); 1002; ; Functionality of mp verified by plasma levels; comparison of IM injections vs. mp; half-life (p. 376) 44-45 hours; animal info (male, female, 115-328 grams); "…pumps delivered the drug at a predictable rate and were efficacious in achieving a constant plasma concentration of amikacin at the predicted level. Osmotic pumps may offer a safer alternative to periodic intramuscular injections for drug delivery in venomous or aggressive snakes." (p. 373); temperatures between 27.2-27.7 C.

P8271 Strieth,S., Eichhorn,M.E., Sutter,A., Jonczyk,A., Berghaus,A., Dellian,M. Antiangiogenic combination tumor therapy blocking alpha v-integrins and VEGF-receptor-2 increases therapeutic effects in vivo. International Journal of Cancer 2006; 119(-2-):423-431. >>> EMD270179; SU5416; DMSO; HCL; SC; IP; Hamster; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by EMD270179 plasma levels; no stress (see pg. 425); half-life (p. 427); "In consideration of the short half-lives of cRGD peptides we decided to apply antiangiogenic cRGD peptides continuously by osmotic pumps." cancer (A-Mel-3); peptides; animal info (syrian golden, 6-8 weeks old, 60 grams); 50% DMSO used; "All animals tolderated pump placement well...in all animals receiving IP osmotic pumps we found quite consistent plasma levels on days 1, 4, 6, and 7 after pump implantation." (p. 425).

P8268 Wilmouth,C.E., Spear,L.P. Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacology Biochemistry and Behavior 2006; 85(-3-):648-657. >>> Nicotine; Saline; SC; Rat; 2002; 7 days; Controls received sham surgery; functionality of mp verified by plasma continine levels; dependence; animal info (male, Sprague-Dawley, 28 days old, 60 days old).

P8264 Sorge,R.E., Stewart,J. The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration. Psychopharmacology 2006; 188(-1-):28-41. >>> Buprenorphine; SC; Rat; 2ML2; 28 days; Controls received sham surgery; functionality of mp verified by plasma buprenorphine levels; dose-response (fig. 1); pumps replaced after 14 days; no stress (see pg. 29); dependence; animal info (male, Long-Evans, 300-350g.).

P8247 Smith,L.N., McDonald,C.G., Bergstrom,H.C., Brielmaler,J.M., Eppolito,A.K., Wheeler,T.L., Falco,A.M., Smith,R.F. Long-term changes in fear conditioning and anxiety-like behavior following nicotine exposure in adult versus adolescent rats. Pharmacology Biochemistry and Behavior 2006; 85(-1-):91-97. >>> Nicotine bitartrate; sodium tartrate; Saline; SC; Rat; 1002; 15 days; Controls received mp w/ sodium tartrate; functionality of mp verified by plasma levels; dose-response (fig 1); animal info (male, female, Long-Evans, 28-42 or 85-99 days old).

P8230 Craven,A.J., Nixon,A.J., Ashby,M.G., Ormandy,C.J., Blazek,K., Wilkins,R.J., Pearson,A.J. Prolactin delays hair regrowth in mice. Journal of Endocrinology 2006; 191(-2-):415-425. >>> Prolactin, ovine; domperidone; Sodium bicarbonate buffer; PEG 400; SC; Mice; 1003D; 1007D; 1002; 3, 12, 14, days; Controls received no treatment; functionality of mp verified by plasma prolactin levels; animal info (Balb/c, 18-30 days old).

P8228 Cheng,C., Tempel,D., van Haperen,R., van der Baan,A., Grosveld,F., Daemen,M.J.A.P., Krams,R., de Crom,R. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006; 113(-23-):2744-2753. >>> Angiotensin II; SC; Mice; 2004; 2 weeks; Functionality of mp verified by mean blood pressure; cardiovascular; peptides; animal info (Apo E -/-).

P8207 Machaalani,R., Waters,K.A. Postnatal nicotine and/or intermittent hypercapnic hypoxia effects on apoptotic markers in the developing piglet brainstem medulla. Neuroscience 2006; 142(-1-):107-117. >>> Nicotine hydrogen tartrate salt; Water, sterile; IP; Pig (neonate); 2ML2; 11-13 days; Controls received mp w/ vehicle; functionality of mp verified by serum cotinine; no stress (see p.109); animal info (mixed-breed miniature piglet, 2 days old, male, female, 1.2 kg).

P8198 Bakardjiev,A.I., Theriot,J.A., Portnoy,D.A. Listeria monocytogenes traffics from maternal organs to the placenta and back. PLoS Pathog 2006; 2(-6-):e66-. >>> Gentamicin sulfate; SC; Guinea-pig (pregnant); 2ML1; ; Functionality of mp verified by plasma levels taken; teratology; listeria.

P8197 Metzger,K.L., Maxwell,C.R., Liang,Y.L., Siegel,S.J. Effects of nicotine vary across two auditory evoked potentials in the mouse. Biological Psychiatry 2006; 61(-1-):23-30. >>> Nicotine, free base; Saline; SC; Mice; 1002; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by plasma nicotine + cotinine levels; animal info (C57BL/6J, DBA/2 Hsd, 10 weeks old).

P8188 Fahey,J.M., Pritchard,G.A., Reddi,J.M., Pratt,J.S., Grassi,J.M., Shader,R.I., Greenblatt,D.J. The effect of chronic lorazepam administration in aging mice. Brain Research 2006; 1118(--):13-24. >>> Lorazepam; PEG 400; SC; Mice; 1, 14 days; Controls received mp w/ vehicle; functionality of mp verified by lorazepam plasma concentrations; tolerance; animal info (male, CD-1, 2-3 months old, 10-12 months old, 22-24 months old).

P8172 Assie,M.B., Lomenech,H., Ravailhe,V., Faucillon,V., Newman-Tancredi,A. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. British Journal of Pharmacology 2006; 149(-2-):170-178. >>> Flesinoxan; F13714; Water, distilled; SC; Rat; 2ML1; 2ML2; 3, 7, 14, days; Controls received mp w/ saline; functionality of mp verified by residual volume; dose-response (fig. 1); animal info (male, Sprague-Dawley, 170, 210, or 250 grams); 2ML1 used for 3 and 7 day treatment.

P8161 Balatsouka,D., Gotfredsen,K., Sorensen,L., Lindh,C.H., Berglundh,T. Effect of systemic administration of nicotine on healing in osseous defects. An experimental study in rabbits. Part II. CLINICAL ORAL IMPLANTS RESEARCH 2006; 17(-5-):488-494. >>> Nicotine hydrogen tartrate salt; Water, sterile; SC; Rabbit; 2ML4; 8 weeks; Controls received mp w/ saline; functionality of mp verified by cotinine plasma levels; long-term study; pumps replaced after 4 weeks; multiple pumps per animal (2); animal info (female, New Zealand white, 9-12 months old, 3-4 kg, osseous defects).

P8147 Kugelberg,F.C., Alkass,K., Kingbaeck,M., Carlsson,B. Influence of blood loss on the pharmacokinetics of citalopram. Forensic Science International 2006; 161(-2-3-):163-168. >>> Citalopram HBr; Saline; propylene glycol; SC; Rat; 2ML2; 6 days; Controls received mp w/ agent without blood loss; functionality of mp verified by residual volume; comparison of oral adminisration vs. mp; no stress (see p.166); good methods; animal info (female, Sprague-Dawley, 250-300g.); mp primed overnight in 37 celsius saline.

P8131 Hashem,G., Zhang,Q., Hayami,T., Chen,J., Wang,W., Kapila,S. Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss. ARTHRITIS RESEARCH&THERAPY 2006; 8(-4-):U186-U194. >>> Relaxin, recomb. human; Saline; SC; Rabbit; 2ML1; 6 days; Controls received mp w/ vehicle; functionality of mp verified by serum relaxin levels; peptides; animal info (female, New Zealand white, 18 wks old).

P8107 Liu,N., Colombi,B., Memmi,M., Zissimopoulos,S., Rizzi,N., Negri,S., Imbriani,M., Napolitano,C., Lai,F.A., Priori,S.G. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia - Insights from a RyR2 R4496C knock- in mouse model. Circulation Research 2006; 99(-3-):292-298. >>> K201; DMSO; IP; Mice; ; Functionality of mp verified by agent plasma concentrations; cardiovascular; animal info (2-3 months old); agent formerly known as JTV519.

P8096 Gosain,A., Matthies,A.M., Dovi,J.V., Barbul,A., Gamelli,R.L., DiPietro,L.A. Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression. Journal of Surgical Research 2006; 135(-2-):218-225. >>> Vascular endothelial growth factor 164, recomb.; platelet-dreived growth factor; fibroblast growth factor-2; Wound site; Mice; 2002; 11 days; Controls received mp w/ PBS; functionality of mp verified by VEGF levels in wound sponges, residual volume; stability verified by activity of residual VEGF in endothelial cell cord formation assay (fig.4); cardiovascular; peptides; animal info (female, BALB/c, 8-9 wks old, implanted sponge wounds); "The activity of VEGF isolated from the pump was comparable to fresh recombinant VEGF 164, confriming that the recombinant growth factors present in the mini-osmotic pump retain robust biological activity." (p.221).

P8091 Josiah,D.T., Vincler,M.A. Impact of chronic nicotine on the development and maintenance of neuropathic hypersensitivity in the rat. Psychopharmacology 2006; 188(-2-):152-161. >>> Nicotine hydrogen tartrate; SC; Rat; 2001; 2ML4; 7, 21 days; Controls received mp w/ saline; functionality of mp verified by plasma nicotine&cotinine levels; dose-response (fig. 1); animal info (male, Sprague-Dawley, 200-300g., spinal nerve ligation).

P8087 Lefebvre,F., Prefontaine,A., Calderone,A., Caron,A., Jasmin,J.F., Villeneuve,L., Dupuis,J. Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure. Clinical Science 2006; 111(-3-):217-224. >>> Angiotensin II; IV (jugular); Rat; 28 days; Controls received sham surgery; functionality of mp verified by plasma Ang II levels; cardiovascular; peptides; animal info (male, Wistar, coronary artery ligation MI, 350-380g).

P8070 Morikawa-Futamatsu,K., Adachi,S., Maejima,Y., Tamamori-Adachi,M., Suzuki,J., Kitajima,S., Ito,H., Isobe,M. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. LIFE SCIENCES 2006; 79(-14-):1380-1390. >>> Angiotensin II; Saline; SC; Rat; 2ML2; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Wistar, 8-11 wks old, 250-300g.).

P7985 Warne,J.P., Horneman,H.F., Wick,E.C., Bhargava,A., Pecoraro,N.C., Ginsberg,A.B., Akana,S.F., Dallman,M.F. Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight, and fat stores. Endocrinology 2006; 147(-11-):5443-5451. >>> Insulin, methylene blue; Saline; IV (jugular); Rat; 2002; ; Functionality of mp verified by dye infusion; replacement therapy (diabetic); no stress (see pg. 5444); good methods; peptides; animal info (male, Sprague-Dawley, 275 grams); diabetes; PE-60 fused to PE-5.

P7972 Zhang,X.W., Lee,T.H., Xiong,X.Y., Chen,Q., Davidson,C., Wetsel,W.C., Ellinwood,E.H. Methamphetamine induces long-term changes in GABAA receptor alpha 2 subunit and GAD67 expression. Biochemical and Biophysical Research Communications 2006; 351(-1-):300-305. >>> Methamphetamine; SC; Rat; 2ML1; 7 days; Controls received mp w/ saline; functionality of mp verified by residual volume; comparison of injections vs. mp; good methods (p. 301); animal info (male, Sprague-Dawley, 300-320 grams); behavioral study.

P7942 Berni,R., Cacciani,F., Zaniboni,M., Savi,M., Bocchi,L., Lapucci,S., Razzetti,R., Pastore,F., Musso,E., Stilli,D. Effects of the alpha 2-adrenergic/DA2-dopaminergic agonist CHF-1024 in preventing ventricular arrhythmogenesis and myocyte electrical remodeling, in a rat model of pressure-overload cardiac hypertrophy. Journal of Cardiovascular Pharmacology 2006; 47(-2-):295-302. >>> CHF-1024; Saline; ascorbic acid; SC; Rat; 2ML4; 1 month; Controls received mp w/ vehicle; functionality of mp verified by plasma levels; dose-response (table 1); stability verified for at least 1 month (pg. 296); cardiovascular; post op. care (gentamicin); animal info (male, Wistar, 6 months old); "a clear dose dependency was found in CHF-1024 plasma levels, indicating a good performance of the osmotic pumps in drug release." (p. 299).

P7938 Bartlett,C.S., Rapuano,B.E., Lorich,D.G., Wu,T., Anderson,R.C., Tomin,E., Hsu,J.F., Lane,J.M., Helfet,D.L. Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification. Bone 2006; 38(-3-):322-332. >>> AH 6809; cyclic AMP, Rp-; IM (vastus intermedius); Rabbit; 2ML2; 14 days; Functionality of mp verified by residual volume; no stress (see pg. 326); animal info (New Zealand); plain and high resolution (Faxitron) radiographs; fig 7 and 9; tissue perfusion (vastus intermedius); agent is a PGE2/PGD receptor antagonist.

P7907 Wagoner,B., Hausman,D.B., Harris,R.B.S. Direct and indirect effects of leptin on preadipocyte proliferation and differentiation. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2006; 290(-6-):R1557-R1564. >>> Leptin, recomb rat; PBS; IP; Rat; 1007D; 5 days; Controls received mp w/ vehicle; functionality of mp verified by serum leptin concentrations; no stress (see pg. R1559); peptides; animal info (male, Sprague-Dawley, 320-340 g).

P7901 Ahern,T.H., Javors,M.A., Eagles,D.A., Martillotti,J., Mitchell,H.A., Liles,L.C., Weinshenker,D. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology 2006; 31(-4-):730-738. >>> Reboxetine; sertraline; desipramine; bupropion; imipramine; venlafaxine; Saline; ethanol; IP; Mice; 2004; 21 days; Controls received mp w/ vehicle; functionality of mp verified by serum drug levels; dose-response (fig. 4); comparison of IP injections vs. mp; stress/adverse reaction: (see pg. 731) Dbh -/- mice did not tolerate mp surgery well and showed signs of general malaise. All other mice strains showed no stress.; post op. care (buprenorphine); animal info (female, male, 3-7 month old; C57BL/6J NET -/- or wt; 257BL/6J 129SvEv Dbh -/-, +/-) 50% ethanol; mp primed 2 days in 37 celsius saline; "we achieved serum levels that fell within or very close to human therapeutic range for each drug with the exception of sertraline." (pg. 732).

P7900 Thompson,E.L., Murphy,K.G., Patterson,M., Bewick,G.A., Stamp,G.W.H., Curtis,A.E., Cooke,J.H., Jethwa,P.H., Todd,J.F., Ghatei,M.A., Bloom,S.R. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2006; 291(-5-):E1074-E1082. >>> Kisspeptin-54; Saline; SC; Rat; 2001D; 2001; 2002; 1, 2, 3, 13 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; comparison of SC injection vs. mp; no stress (see pg. E1078); stability verified by 14 days in mp in 37 celsius saline (see fig. 2); good methods pg. E1075; peptides; post op. care (flucloxacillin, amoxicillin); animal info (male, Wistar, 275-325g.); mp primed for 3hrs. (2001D) or overnight (2001, 2002) in 37 celsius saine; "animals were healthy throughout the study period. No adverse behaviors were observed in any of the treatment groups at any point during the study." (pg. E1078).

P7888 da Silva,A.A., Tallam,L.S., Liu,J.K., Hall,J.E. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2006; 291(-5-):R1275-R1282. >>> Leptin; Saline; CSF/CNS; Rat; 2002; 10 days; Controls received IV saline; functionality of mp verified by plasma leptin concentrations; comparison of IV infusion vs. mp; cardiovascular; peptides; animal info (male, Sprague-Dawley, 275-325g.).

P7868 Marengo,S.R., Chen,D.H.C., Evan,A.P., Sommer,A.J., Stowe,N.T., Ferguson,D.G., Resnick,M.I., MacLennan,G.T. Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. UROLOGICAL RESEARCH 2006; 34(-3-):200-210. >>> Potassium oxalate; oxalic acid, 14c-; PBS; SC; Rat; 2ML1; 13 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume and in vitro 14c-oxalic acid mp into PBS, scintillation counting; dose-response (fig. 2); pumps replaced after 6 days; no stress (see pg. 203); good methods pg. 201-203; post op. care (bupivacaine); animal info (male, Sprague-Dawley, 200-250g.); mp primed 24 hours in 25 celsius PBS; "The osmotic minipump makes possible an oxalate direct in vivo model for the study of CaOx nephrocalcinosis and interactions between oxalate and the kidney." (pg. 209).

P7865 Rizk,P., Salazar,J., Raisman-Vozari,R., Marien,M., Ruberg,M., Colpaert,F., Debeir,T. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal Neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006; 31(-6-):1146-1157. >>> Dexefaroxan; Water, distilled; SC; Rat; 2ML4; 20, 21, 28, 70 days; Controls received mp w/ vehicle; functionality of mp verified by monitoring inhibition of hypothermia; comparison of IP injections vs. mp; long-term study; pumps replaced every 28 days; neurodegenerative (Alzheimer's disease); animal info (male, Sprague-Dawley, 250-300g.); alpha2-adrenoceptor antagonist.

P7862 Ran,J.M., Hirano,T., Fukui,T., Saito,K., Kageyama,H., Okada,K., Adachi,M. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. METABOLISM-CLINICAL AND EXPERIMENTAL 2006; 55(-4-):478-488. >>> Angiotensin II, human; PD123319; CGP42112A; Saline; SC; Rat; 1007D; 2ML1; 2ML2; 7, 14 days; Controls received mp w/ vehicle; functionality of mp verified by plasma angiotensin II levels; dose-response (table 1); no stress (see pg. 482); peptides; multiple pumps per animal (2); animal info (male, Wistar, 8 wk. old, 400g.).

P7860 Pun,S., Santos,A.F., Saxena,S., Xu,L., Caroni,P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nature Neuroscience 2006; 9(-3-):408-419. >>> Ciliary neurotrophic factor, recomb. rat; glial-derived neurotrophic factor, recomb. human; PBS; BSA; IM (triceps surae); Mice (transgenic); 1002; ; Controls received mp w/ vehicle; functionality of mp verified by residual volume; peptides; neurodegenerative (motoneuron disease); animal info (Tg G93A SoD1, G85R S0D1).

P7852 Shimizu,H., Nakagami,H., Tsukamoto,I., Morita,S., Kunugiza,Y., Tomita,T., Yoshikawa,H., Kaneda,Y., Ogihara,T., Morishita,R. NF kappa B decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Therapy 2006; 13(-12-):933-941. >>> Oligodeoxynucleotide, antisense; oligodeoxynucleotide, missense; oligodeoxynucleotide, FITC-, antisense; Rat; 2004; 2, 4 weeks; Controls received mp w/ missense ODN; functionality of mp verified by FITC-ODN fluorescence detection in tibia; antisense (NFkB); animal info (female, Wistar, 10 wk. old; male, Wistar-ODS, 8 wk. old).

P7847 Morato,M., Pinho,D., Sousa,T., Guimaraes,S., Moura,D., Albino-Teixeira,A. Pre- and postiunctional effects of angiotensin II in hypertension due to adenosine receptor blockade. European Journal of Pharmacology 2006; 531(-1-3-):209-216. >>> DPSPX; Saline; IP; Rat; 2ML1; 3, 7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; animal info (male, Wistar, 250-300g.); 1, 3 dipropyl-8-sulfophenylxanthine; adenosine receptor anagonist.

P7841 Buss,S.J., Backs,J., Kreusser,M.M., Hardt,S.E., Maser-Gluth,C., Katus,H.A., Haass,M. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. Endocrinology 2006; 147(-5-):2526-2534. >>> Aldosterone, D-; Rat; 2004; 28 days; Controls received mp w/ vehicle; functionality of mp verified by plasma aldosterone levels; cardiovascular; animal info (male, Wistar, 200g.).

P7825 Pitas,G., Laurenzana,E.M., Williams,D.K., Owens,S.M., Gentry,W.B. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Drug Metabolism and Disposition 2006; 34(-6-):906-912. >>> Phencyclidine HCL; Saline, sterile; SC; Rat; 2ML1; 4 days; Functionality of mp verified by serum PCP concentrations; half-life (pg. 907) 3.9 hours in rats; tolerance; animal info (male, Sprague-Dawley, 270-300g.).

P7821 Cao,Z.X., Gao,Y., Bryson,J.B., Hou,J.W., Chaudhry,N., Siddiq,M., Martinez,J., Spencer,T., Carmel,J., Hart,R.B., Filbin,M.T. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. Journal of Neuroscience 2006; 26(-20-):5565-5573. >>> Interleukin-6, recomb. rat; Saline; CSF/CNS (intrathecal); Rat; 1002; 2 weeks; 24 hours; Controls received mp w/ vehicle; functionality of mp verified by residual volume; dose-response (fig. 7); no stress (see pg. 5571); peptides; animal info (female, Long-Evans, pg. 21-pg. 23; bilateral dorsal column lesion, 8wk old); mp primed at least 4 hours at 37 celsius.

P7815 Goldstein,D.M., Alfredson,T., Bertrand,J., Browner,M.F., Clifford,K., Dalrymple,S.A., Dunn,J., Freire-Moar,J., Harris,S., Labadie,S.S., La Fargue,J., Lapierre,J.M., Larrabee,S., Li,F.J., Papp,E., McWeeney,D., Ramesha,C., Roberts,R., Rotstein,D., San Pablo,B., Sjogren,E.B., So,O.Y., Talamas,F.X., Tao,W., Trejo,A., Villasenor,A., Welch,M., Welch,T., Weller,P., Whiteley,P.E., Young,K., Zipfel,S. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3- dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 map kinase. Journal of Medicinal Chemistry 2006; 49(-5-):1562-1575. >>> R03201195; PEG 400; SC; Rat; 14 days; Controls received mp w/ vehicle; functionality of mp verified by plasma concentrations; pumps replaced on day 8; enzyme inhibitor (p38 map kinase); multiple pumps per animal (2); animal info (female, Lewis, 120-150g., rat adjuvant arthritis).

P7813 Heffernan,D., Dudley,B., McNeil,P.L., Howdieshell,T.R. Local arginine supplementation results in sustained wound nitric oxide production and reductions in vascular endothelial growth factor expression and granulation tissue formation. Journal of Surgical Research 2006; 133(-1-):46-54. >>> Arginine, L-; Saline; Wound site; Pig; 2ML2; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; animal info (female, domestic, Landrace, 15-20kg., hernia defect); tubing was looped and contained multiple side holes to ensure uniform delivery within the aqueous wound compartment; ultrasonography.

P7811 Krol,E., Duncan,J.S., Redman,P., Morgan,P.J., Mercer,J.G., Speakman,J.R. Photoperiod regulates leptin sensitivity in field voles, Microtus agrestis. JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY 2006; 176(-2-):153-163. >>> Leptin, recomb. mouse; PBS; SC; Vole; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by serum leptin levels; peptides; animal info (male, field vole (microtus agrestis), 20-23 wk old, 26g.); "the osmotic pumps were effective in delivering biologically active hormone to the animals." (pg. 160).

P7810 Liu,H.H., Payne,H.R., Wang,B., Brady,S.T. Gender differences in response of hippocampus to chronic glucocorticoid stress: Role of glutamate receptors. Journal of Neuroscience Research 2006; 83(-5-):775-786. >>> Corticosterone; PEG; SC; Mice; 2002; 2 weeks; Controls received no treatment; functionality of mp verified by plasma corticosterone levels; animal info (male, female, C57BL/6J, 7 wk old); "Although daily injections do elevate plasma corticosterone chronically, animals experience spikes of corticosterone associated with both handling and injection" (pg. 776).

P7802 Oberbeck,R., Schmitz,D., Wilsenack,K., Schueler,M., Husain,B., Schedlowski,M., Exton,M.S. Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Medicine 2006; 32(-5-):731-739. >>> Dopamine; IP; Mice; 48 hours; Controls received mp w/ saline; functionality of mp verified by dopamine plasma concentration; animal info (male, NMRI, 8-9 wk old, 30-34-g.); laparotomy or polymicrobial sepsis induced by cecal ligation and puncture.

P7798 Zhang,H.J., Doctrow,S.R., Oberley,L.W., Kregel,K.C. Chronic antioxidant enzyme mimetic treatment differentially modulates hyperthermia-induced liver HSP70 expression with aging. Journal of Applied Physiology 2006; 100(-4-):1385-1391. >>> EUK-189; Water, distilled; SC; Rat; 2004; 30 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; animal info (male, Fischer 344, 6 month old, 300-400g., 24 month old, 350-450g.).

P7785 Jin,X.L., Zimmers,T.A., Perez,E.A., Pierce,R.H., Zhang,Z.X., Koniaris,L.G. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 2006; 43(-3-):474-484. >>> Interleukin-6, recomb. mouse; Saline, sterile; IP; Mice; 7 days; Controls received mp w/ vehicle; functionality of mp verified by serum IL-6 levels; peptides; animal info (male, C57BL6/J).

P7775 Pinho,D., Sousa,T., Morato,M., Tavares,I., bino-Teixeira,A. Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats. Brain Research 2006; 1073(--):374-382. >>> Sulfophenylxanthine,1,3-dipropyl-8-; IP; Rat; 2ML1; 7 days; Controls received mp w/ saline; functionality of mp verified by blood pressure; cardiovascular; animal info (male, Wistar, 285-310g.); adenosine receptor antagonist.

P7766 Takakura,T., Takimoto,A., Notsu,Y., Yoshida,H., Ito,T., Nagatome,F., Ohno,M., Kobayashi,Y., Yoshioka,T., Inagaki,K., Yagi,S., Hoffman,R.M., Esaki,N. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine -lyase conjugated with polyethylene glycol as an antitumor agent. Cancer Research 2006; 66(-5-):2807-2814. >>> Pyridoxal 5'-phosphate; Sodium phosphate buffer; SC; Mice; 2001; 3 days; Functionality of mp verified by plasma PLP concentrations; cancer; animal info (BALB/c AnNCrj, female, 8-10 wk old, 20-22g); "we believe that DTT-treated PEG-METase should be used together with PLP infusion to minimize the dose&frequency of administration to increase efficacy" (p.2813).

P7753 French,K.L., Granholm,A.C.E., Moore,A.B., Nelson,M.E., Bimonte-Nelson,H.A. Chronic nicotine improves working and reference memory performance and reduces hippocampal NGF in aged female rats. Behavioural Brain Research 2006; 169(-2-):256-262. >>> Nicotine ditartrate; Saline, sterile; SC; Rat; 4 weeks; Controls received mp w/ vehicle; functionality of mp verified by cotinine plasma concentrations; dose-response (fig 1); no stress (see pg. 258); neurodegenerative (Alzheimer's disease, Parkinson's disease); animal info (Fisher-344, female, 24 month old).

P7752 Chamberlain,J., Evans,D., King,A., Dewberry,R., Dower,S., Crossman,D., Francis,S. Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. American Journal of Pathology 2006; 168(-4-):1396-1403. >>> Interleukin-1 receptor antagonist; SC; Mice; 4 weeks; Controls received mp w/ placebo; functionality of mp verified by agent serum levels; cardiovascular; animal info (male, 8-12 wk old).

P7734 Pech,V., Sikka,S.C., Sindhu,R.K., Vaziri,N.D., Majid,D.S.A. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets. American Journal of Hypertension 2006; 19(-5-):534-540. >>> Angiotensin II; SC; Rat; 2002; 14 days; Functionality of mp verified by mean arterial pressure; cardiovascular; peptides; animal info (Sprague-Dawley, male 225-325g.).

P7730 King,V.L., Trivedi,D.B., Gitlin,J.M., Loftin,C.D. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2006; 26(-5-):1137-1143. >>> Angiotensin II; Saline; SC; Mice; 2004; 28 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, C57BL/6J, apoE -/-, 8-10 wk old).

P7729 Duka,A., Schwartz,F., Duka,I., Johns,C., Melista,E., Gavras,I., Gavras,H. A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice. American Journal of Hypertension 2006; 19(-3-):275-281. >>> Angiotensin II; Saline; SC; Mice; 2001; 7,14 days; Controls received mp w/ saline; functionality of mp verified by systolic blood pressure; comparison of acute IV infusion vs. mp; cardiovascular; peptides; animal info (male, C57BL/6J, 8-10 wk. old).

P7728 Frielingsdorf,H., Thal,L.J., Pizzo,D.P. The septohippocampal cholinergic system and spatial working memory in the Morris water maze. Behavioural Brain Research 2006; 168(-1-):37-46. >>> Nerve growth factor, recomb. human; CSF, artificial; gentamicin; albumin, rat serum; CSF/CNS; Rat; 2004; 4 weeks; Controls received mp w/ vehicle; functionality of mp verified by residual volume; cannula placement confirmed by cresyl violet staining; peptides; animal info (male, Fisher 344, 13-14 wk. old, medial septum lesion, 400g); mp primed 2 days in 37 Celsius saline.

P7726 Gould,G.G., Altamirano,A.V., Javors,M.A., Frazer,A. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biological Psychiatry 2006; 59(-5-):408-414. >>> Venlafaxine; sertraline; amitriptyline; paroxetine; desipramine; citalopram; Saline; water, deionized; ethanol; SC; Rat; 2ML4; 21 days; Controls received mp w/ vehicle; functionality of mp verified by serum drug concentrations; dose-response (fig1); anmial info (male, Sprague-Dawley, 150-200g); 50% EtoH in H2O.

P7710 Lohmus,M., Sundstroem,L.F., Silverin,B. Chronic administration of leptin in Asian Blue Quail. JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-COMPARATIVE EXPERIMENTAL BIOLOGY 2006; 305A(-1-):13-22. >>> Leptin, recomb. chicken; PBS; SC; Bird (quail); 1002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume at 3 time points; peptides; animal info (male, asian blue quail, 50 g, young).

P7643 Wang,D., Chabrashvili,T., Borrego,L., Aslam,S., Umans,J.G. Angiotensin II infusion alters vascular function in mouse resistance vessels: Roles of O2 BULL - and endothelium. JOURNAL OF VASCULAR RESEARCH 2006; 43(-1-):109-119. >>> Angiotensin II; Saline; SC; Mice; 1002; 12-14 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (C57BL/6, male, 20-25 g).

P7582 Cardoso,A., Paula-Barbosa,M.M., Lukoyanov,N.V. Reduced density of neuropeptide Y neurons in the somatosensory cortex of old male and female rats: Relation to cholinergic depletion and recovery after nerve growth factor treatment. Neuroscience 2006; 137(-3-):937-948. >>> Dye, methylene blue; nerve growth factor; CSF, artificial; BSA; CSF/CNS; Rat; 2002; 14 days; Controls received mp w/ vehicle or sham surgery; functionality of mp verified by pretesting; Alzet brain infusion kit used; post op. care (antiseptic); animal info (male, female, Wistar 6 month old, 24 month old); Lynch coil filled with NGF, air-oil spacer between mp and catheter, mp filled with dye.

P7573 Mark,P.J., Smith,J.T., Waddell,B.J. Placental and fetal growth retardation following partial progesterone withdrawal in rat pregnancy. PLACENTA 2006; 27(-2-3-):208-214. >>> Estradiol; Propylene glycol; SC; Rat (pregnant); 6 days; Controls received sham operation and 2x daily injection of vehicle; functionality of mp verified by plasma estradiol concentrations; replacement therapy (ovariectomy); animal info (female, albino Wistar, 3-5 month old).

P7550 Ma,Y.W., Zhang,L.P., Peng,T., Cheng,J.Z., Taneja,S., Zhang,J.Q., Delafontaine,P., Du,J. Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: Role of nuclear factor-kappaB. Endocrinology 2006; 147(-3-):1256-1263. >>> Angiotensin II; Ringer's solution; SC; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 3 months old); endocrinology.

P7519 Kennedy,D.J., Vetteth,S., Periyasamy,S.M., Kanj,M., Fedorova,L., Khouri,S., Kahaleh,M.B., Xie,Z.J., Malhotra,D., Kolodkin,N.I., Lakatta,E.G., Fedorova,O.V., Bagrov,A.Y., Shapiro,J.I. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006; 47(-3-):488-495. >>> Marinobufagenin; Rat; 2004; 4 weeks; Controls received sham operation; functionality of mp verified by agent plasma levels; comparison of partial nephrectomy vs. mp; stability verified for 4 weeks at 37 C by comparable inhibition of 86Rb uptake; cardiovascular; animal info (male, Sprague-Dawley).

P7497 Elitok,S., Brodsky,S.V., Patschan,D., Orlova,T., Lerea,K.M., Chander,P., Goligorsky,M.S. Cyclic arginine-glycine-aspartic acid peptide inhibits macrophage infiltration of the kidney and carotid artery lesions in apo-E-deficient mice. American Journal of Physiology-Renal Physiology 2006; 290(-1-):F159-F166. >>> Peptide, CRGD; peptide, CRAD; SC; Mice; 1002; 2004; 14, 28 days; Controls received mp w/ PBS; functionality of mp verified by platelet aggregation inhibitory properties and residual volume; dose-response (fig. 3); stability verified by mass spec of residual volume; half-life (p. F160); peptides; animal info (female, C57BL6, 7 weeks, 290 g); cartoid artery ligation.

P7491 Kopkan,L., Castillo,A., Navar,L.G., Majid,D.S.A. Enhanced superoxide generation modulates renal function in ANG II- induced hypertensive rats. American Journal of Physiology-Renal Physiology 2006; 290(-1-):F80-F86. >>> Angiotensin II; SC; Rat; 2002; 2 weeks; Controls received no treatment; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 220-250 grams).

P7489 Lee,D.L., Sturgis,L.C., Labazi,H., Osborne,JB Jr, Fleming,C., Pollock,J.S., Manhiani,M., Imig,J.D., Brands,M.W. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. American Journal of Physiology-Heart and Circulatory Physiology 2006; 290(-3-):H935-H940. >>> Angiotensin II; SC; Mice; 2 weeks; Controls received mp w/ saline or no treatment; functionality of mp verified by mean arterial pressure; cardiavascular; peptides; animal info (male, C57BL6 and IL-6 knockout).

P7468 Kim,J.H., Bronson,C.L., Hayton,W.L., Radmacher,M.D., Roopenian,D.C., Robinson,J.M., Anderson,C.L. Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006; 290(-2-):G352-G360. >>> Leucine, 3H-; SC; Mice; 1002; 2 weeks; Controls received mp w/ agent and were WT mice; functionality of mp verified by residual volume and steady state plasma concentrations of labeled proteins; comparison of IV bolus injections vs. mp; half-life (p. G353)<15 minutes; immunology; animal info (C57BL/6J, FcRn a-chain, knockout, male 28 g); mp primed 4 hours in 37C isotonic saline.

P7451 Fekete,C., Singru,P.S., Sanchez,E., Sarkar,S., Christoffolete,M.A., Riberio,R.S., Rand,W.M., Emerson,C.H., Bianco,A.C., Lechan,R.M. Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 2006; 147(-1-):520-529. >>> Leptin, recomb. mouse; insulin; glucose; CSF, artificial; CSF/CNS; Rat; 1003D; 3 days; Controls received mp w/ vehicle; functionality of mp verified by agent levels in CSF+ serum; peptides; post op. care (bacitracin ointment); animal info (male Sprague-Dawley, 200-250 g); cannula placement confirmed by light microscope.

P8606 Hagg,T., Baker,K.A., Emsley,J.G., Tetzlaff,W. Prolonged local neurotrophin-3 infusion reduces ipsilateral collateral sprouting of spared corticospinal axons in adult rats. Neuroscience 2005; 130(-4-):875-887. >>> Neurotrophin-3, recomb. human; PBS; gentamicin; albumin, rat serum; CSF/CNS (intrathecal); Rat; 2002; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; dose-response (fig. 4); stability verified by activity assay of residual mp content after 14 days in vivo; ALZET brain infusion kit used; peptides; post op. care (Penicillin G, buprenorphine); animal info (Sprague-Dawley, 3 months old, 200-220 grams, partial resection of corticospinal tract); schematic of mp p. 877 fig 2.

P8238 du Plessis,I., Mitchell,D., Laburn,H.P., Cartmell,T. Fever and lethargy induced by subcutaneous pyrogen infusion in unrestrained rats. Canadian Journal of Physiology and Pharmacology 2005; 83(-11-):1007-1014. >>> Endotoxin, LPS; muramyl dipeptide; Saline, sterile; SC; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by weight; peptides; animal info (male, Sprague-Dawley, 250-350 grams).

P8101 van der Wouden,E.A., Henning,R.H., Deelman,L.E., Roks,A.J.M., Boomsma,F., de Zeeuw,D. Does angiotensin (1-7) contribute to the antiproteinuric effect of ACE-inhibitors?. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 2005; 6(-2-):96-101. >>> Angiotensin (1-7); angiotensin (1-7), [D-Ala7]-; IV (jugular); Rat; 2002; 2 weeks; Controls received mp w/ saline; functionality of mp verified by plasma agent levels; animal info (male, Wistar, 275-300g., adriamycin-induced proteinuria); nephrology.

P7776 Stoyanovitch,A.G., Johnson,M.A., Clifton,D.K., Steiner,R.A., Fraley,G.S. Galanin-like peptide rescues reproductive function in the diabetic rat. Diabetes 2005; 54(-8-):2471-2476. >>> Galanin-like peptide; antibody, anti-GALP; immunoglobulin G, goat; CSF, artificaial; CSF/CNS; Rat; 2002; 11 days; Controls received mp w/ vehicle, or IgG; functionality of mp verified; AlZET brain infusion kit 2 used; peptides; animal info (adult, male, Sprague-Dawley, 280-320g.); catheter filled with vehicle to allow 6.5 days delay treatment before agent; cannula placement confirmed.

P7756 Shibuya,K., Kanasaki,K., Isono,M., Sato,H., Omata,M., Sugimoto,T., Araki,S.I., Isshiki,K., Kashiwagi,A., Haneda,M., Koya,D. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 2005; 54(-3-):838-845. >>> Peptide, Ac-SDKP; Balanced salt solution; SC; Mice; 2004; 8 weeks; Controls received mp w/ vehicle, or controld peptide; functionality of mp verified by plasma AC-SDKP levels; replacement therapy (diabetes); long-term study; pumps replaced at 4 weeks; no stress (see pg. 839, 843); peptides; animal info (male, db/db, db/m, 10 wk. old).

P7733 Kimura,S., Zhang,G.X., Nishiyama,A., Shokoji,T., Yao,L., Fan,Y.Y., Rahman,M., Abe,Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases - Comparison of angiotensin II and diazoxide. Hypertension 2005; 45(-3-):438-444. >>> Angiotensin II; Rat; 14 days; Controls received sham operation; functionality of mp verified by mean blood pressure; comparison of acute infusion vs. mp; cardiovascular; peptides; animal info (male, Sprague-Dawley, 10 wk old).

P7712 Iida-Klein,A., Lu,S.S., Kapadia,R., Burkhart,M., Moreno,A., Dempster,D.W., Lindsay,R. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. Journal of Endocrinology 2005; 186(-3-):549-557. >>> Parathyroid hormone, human 1-34; PBS; acetic acid; SC; Mice; 1002; 2 weeks; Controls received mp w/ vehicle; functionality of mp verified by hPTH 1-34 serum levels; comparison of SC injections vs. mp; no stress (see pg. 553, 556); peptides; animal info (female, C57BL/J6, 10 wk. old, 18 g); "No animals showed abnormal movements or signs of stress or discomfort at any point in any experiment." (p. 553).

P7711 Lindros,K.O., Jaervelaeinen,H.A. Chronic systemic endotoxin exposure: An animal model in experimental hepatic encephalopathy. METABOLIC BRAIN DISEASE 2005; 20(-4-):393-398. >>> Endotoxin, LPS; IV (jugular); Rat; 2ML4; 4 weeks; Functionality of mp verified by plasma endotoxin levels; tolerance; tubing contains pyrogen-free saline to delay agent delivery by 36 h..

P7693 Kato,T., Muraski,J., Chen,Y., Tsujita,Y., Wall,J., Glembotski,C.C., Schaefer,E., Beckerle,M., Sussman,M.A. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. Journal of Clinical Investigation 2005; 115(-10-):2716-2730. >>> Atrial natriuretic peptide; Saline; SC; Mice (transgenic); mice; 24 hours; Controls received mp w/ vehicle; functionality of mp verified by ANP plasma levels; half-life (p. 2727) "a few minutes;" cardiovascular; peptides; animal info (FVBN/J); "the short half-life of ANP...prompted use of an osmotic pump for prolonged release." (p. 2727).

P7679 Davis,J.A., James,J.R., Siegel,S.J., Gould,T.J. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. Journal of Neuroscience 2005; 25(-38-):8708-8713. >>> Nicotine; Saline; SC; Mice; 1002; 2 weeks; Functionality of mp verified by nicotine plasma levels; animal info (C57BL/6, 8-12 weeks old).

P7672 Gorin,Y., Block,K., Hernandez,J., Bhandari,B., Wagner,B., Barnes,J.L., Abboud,H.E. Nox4 NAD(P) H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. Journal of Biological Chemistry 2005; 280(-47-):39616-39626. >>> Oligonucleotide, phosphorothioate antisense; oligonucleotide, phosphorothioate sense; SC; Rat; 2 weeks; Controls received mp w/ sense oligo or not treatment; functionality of mp verified by Nox4 levels in kidney cortex; replacement therapy (STZ-induced diabetes); anti-sense (Nox4); animal info (male, Sprague-Dawley, 200-225 g).

P7668 Hasuike,S., Ido,A., Uto,H., Moriuchi,A., Tahara,Y., Numata,M., Nagata,K., Hori,T., Hayashi,K., Tsubouchi,H. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. Journal of Gastroenterology and Hepatology 2005; 20(-11-):1753-1761. >>> Hepatocyte growth factor, recomb. human; PBS; IP; Rat; 7 days; Controls received mp w/ vehicle; functionality of mp verified by human HGF serum levels; replacement therapy (hepatectomy); half-life (pg. 1758)<3 min; animal info (male, Fisher, 8 wk. old).

P7656 Jaimes,E.A., Tian,R.X., Pearse,D., Raij,L. Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species. Kidney International 2005; 68(-5-):2143-2153. >>> Angiotensin II; SC; Rat; 1007D; 5 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley 6 wk. old).

P7642 Sahu,A., Metlakunta,A.S. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion. Journal of Neuroendocrinology 2005; 17(-11-):720-726. >>> Leptin, recomb. murine; CSF, artificial; CSF/CNS; Rat; 2002; 9, 23 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; pumps replaced after 7 days; peptides; animal info (male, Sprague-Dawley 250-300 g, adult); all animals received aCSF for 7 days, then agent or vehicle for 2 or 16 days.

P7639 Zhou,M.S., Jaimes,E.A., Raij,L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. Journal of Hypertension 2005; 23(-9-):1737-1743. >>> Angiotensin II; Saline; SC; Rat; 1007D; 5 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley 250-300 g).

P7626 Rousseau,K., Atcha,Z., Denton,J., Cagampang,F.R.A., Ennos,A.R., Freemont,A.J., Loudon,A.S.I. Skeletal bone morphology is resistant to the high amplitude seasonal leptin cycle in the Siberian hamster. Journal of Endocrinology 2005; 186(-3-):475-479. >>> Leptin, recomb. murine; PBS; SC; Hamster; 1007D; 14 days; Controls received mp w/ vehicle; functionality of mp verified by serum leptin levels; pumps replaced at 1 week; peptides; animal info (male, Siberian, 16 wk old, 38 g).

P7616 Eiden,S., Simon,E., Schmidt,I. Dose-related steady states of fat loss in long-term leptin-treated ob/ob mice: Leptin resistance or desensitization versus counterregulatory signaling. JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY 2005; 175(-7-):487-497. >>> Leptin, recomb. murine His 6-tagged; Saline; SC; Mice; 1002; 55, 60 days; Controls received mp w/ agent and were 2 months old; functionality of mp verified by residual volume; dose-response (fig 1); long-term study; pumps replaced every 15 days; no stress (see pg.488); peptides; animal info (C57B1/6J, male, ob/ob; 2 or 5 months old 33 g, 58 g).

P7612 Gupta,A.K., Cerniglia,G.J., Mick,R., McKenna,W.G., Muschel,R.J. HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. Cancer Research 2005; 65(-18-):8256-8265. >>> Amprenavir; SC; Mice (nude); 1-4, 2-15 days; Controls received mp w/ vehicle; functionality of mp verified by serum drug levels by HPLC; no stress (see pg.826); enzyme inhibitor (HIV protease); cancer (SQ208, head and neck, T24 bladder); animal info (female, Ncr- nu/nu); irradiation.

P7611 Huang,G.J., Herbert,J. The role of 5-HT(1A) receptors in the proliferation and survival of progenitor cells in the dentate gyrus of the adult hippocampus and their regulation by corticoids. Neuroscience 2005; 135(-3-):803-813. >>> DPAT, 8-OH-; WAY-100,635; Saline; SC; Rat; 2ML2; 14 days; Controls received mp w/ vehicle; functionality of mp verified by residual volume; comparison of SC injections vs. mp; half-life (pg. 810); animal info (male, Lister hooded, 250-300 g); 5-HT 1A agonist; 5-HT 1A antagonist; "The use of osmotic pumps may be more effective than daily injection because of the short half-life of 8-OH-DPAT." (p. 810).

P7609 Wu,R.Q., Dong,W.F., Zhou,M., Cui,X.X., Simms,H.H., Wang,P. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovascular Research 2005; 68(-2-):318-326. >>> Ghrelin, rat; PD 142893; Saline, normal; IV (jugular); Rat; 2001D; 15 hours; Controls received mp w/ vehicle or sham operated; functionality of mp verified by plasma levels; half-life (pg. 324) 11-17 min. in rat; cardiovascular; peptides; animal info (male, Sprague-Dawley 275-325 g); cecal ligation.

P7598 Rikitake,Y., Oyama,N., Wang,C.Y.C., Noma,K., Satoh,M., Kim,H.H., Liao,J.K. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1(+/-) haploinsufficient mice. Circulation 2005; 112(-19-):2959-2965. >>> Angiotensin II; Saline; SC; Mice; 2004; 28 days; Controls received mp w/ vehicle; functionality of mp verified by systolic blood pressure; no stress (see pg.2961); cardiovascular; peptides; animal info (C57BL/6J, male, 8-12 weeks); echocardiology.

P7597 De Ciuceis,C., Amiri,F., Brassard,P., Endemann,D.H., Touyz,R.M., Schiffrin,E.L. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice - Evidence for a role in inflammation in angiotensin-induced vascular injury. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2005; 25(-10-):2106-2113. >>> Angiotensin II, I6 5-; Saline; SC; Mice (transgenic); 14 days; Controls received mp w/ vehicle or no treatment; functionality of mp verified by systolic blood pressure; no stress (see pg.2108); cardiovascular; peptides; animal info (12-16 weeks old); DSI radiotelemetry devices implanted..

P7595 Danzi,S., Dubon,P., Klein,I. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. American Journal of Physiology-Heart and Circulatory Physiology 2005; 289(-4-):H1506-H1511. >>> Triiodothyronine; NaOH; saline; SC; Rat; 1002; 3, 12 days; Controls received mp w/ vehicle or euthyroid; functionality of mp verified by serum T3 levels; replacement therapy (thyroidectomy); dose-response (fig. 1); comparison of IM injections vs. mp; half-life (pg. H1506, H1508) 7 hours in vivo in rat; cardiovascular; animal info (male, Sprague-Dawley 200 g); mp primed 24 hrs in 37 C saline; "constant infusions leads to stable serum levels by 72 h." (p. H1508; "Bolus injection was not sufficient to normalize serum T3" (p. H1510).

P7589 Gemma,C., Fister,M., Hudson,C., Bickford,P.C. Improvement of memory for context by inhibition of caspase-1 in aged rats. European Journal of Neuroscience 2005; 22(-7-):1751-1756. >>> YVAD-CMK, Ac-; CSF/CNS; Rat; 2004; 28 days; Controls received mp w/ 0.6% DMSO in saline; functionality of mp verified by mp weight (not suggested by manufacturer); enzyme inhibitor (caspase -1); immunology; animal info (young, aged, make, Fischer 344 g); mp primed 48 hr in 37 C sterile saline.

P7572 Saghir,S.A., Lebofsky,M., Pinson,D.M., Rozman,K.K. Validation of Haber's Rule (dose x time = constant) in rats and mice for monochloroacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin under conditions of kinetic steady state. Toxicology 2005; 215(-1-2-):48-56. >>> Monochloroacetic acid; monochloroacetic acid; Saline, physiological; radio-isotopes; 14C tracer; SC; Rat; 2001D; 2-10 hours; Functionality of mp verified by radioactivity in plasma; dose-response (table 2); comparison of IV injections vs. mp; half-life (pg. 49) 2-3 hours; toxicology; animal info (male, Sprague-Dawley, 171 g); PE-60 tubing filled with saline attached to mp to.

P7571 Sarkis,A., Ito,O., Mori,T., Kohzuki,M., Ito,S., Verbalis,J., Cowley,AW Jr, Roman,R.J. Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus. American Journal of Physiology-Renal Physiology 2005; 289(-6-):F1333-F1340. >>> Oxytocin; Saline; IP; Rat; 2002; 8 days; Controls received mp w/ vehicle; functionality of mp verified by plasma oxytocin levels; animal info (male, Brattleboro, Long-Evans, 9-10 wk old); vasopressin agonist.

P7559 Chan,C.C.M., Khodarahmi,K., Liu,J., Sutherland,D., Oschipok,L.W., Steeves,J.D., Tetzlaff,W. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Experimental Neurology 2005; 196(-2-):352-364. >>> Y-27632; streptomycin; PBS, sterile; penicillin; CSF/CNS (intrathecal); Rat; 2002; 2 weeks; 2, 4 days; Controls received mp w/ vehicle; functionality of mp verified by ROCK inhibitory activity in CSF; dose-response (fig. 3); stability of Y27632 verified by ROCK inhibitory activity after 13 days in mp at 37 C; enzyme inhibitor (RHO Kinase); animal info (male, Sprague-Dawley); cervical 4/5 dorsal column transection.

P7557 Karram,T., Abbasi,A., Keidar,S., Golomb,E., Hochberg,I., Winaver,J., Hoffman,A., Abassi,Z. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. American Journal of Physiology-Heart and Circulatory Physiology 2005; 289(-4-):H1351-H1358. >>> Spironolactone; eprosartan; PEG 400; sodium bicarbonate; IP; Rat; 2ML2; 2ML4; 14, 28 days; Controls received mp w/ vehicle; functionality of mp verified by plasma levels (H1353); cardiovascular; animal info (male, Wistar 300 g); aldosterone antagonist; ANG II receptor antagonist.

P7546 Ding,B., Abe,J., Wei,H., Xu,H.D., Che,W.Y., Aizawa,T., Liu,W.M., Molina,C.A., Sadoshima,J., Blaxall,B.C., Berk,B.C., Yan,C. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2005; 102(-41-):14771-14776. >>> Angiotensin II; SC; Rat; 2001; 7 days; Controls received mp w/ vehicle; functionality of mp verified by systolic and diastolic blood pressure; no stress (see pg. 14772); cardiovascular; peptides; animal info (Sprague-Dawley).

P7543 Cryan,J.F., Page,M.E., Lucki,I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 2005; 182(-3-):335-344. >>> Reboxetine hydrobromide; fluoxetine hydrobromide; moclobemide; Ethanol; saline; SC; Rat; 2ML1; 2ML2; 3, 14 days; Controls received mp w/ vehicle or saline; functionality of mp verified by residual volume; dose-response (fig. 1); post op. care (providone-iodine antiseptic ointment); animal info (male, Sprague-Dawley, 350-500 g); 50% ethanol.

P7532 Helander,H.F., Li,H. Cell proliferation in the gastric epithelium of the ulcer rat. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2005; 40(-12-):1386-1393. >>> Thymidine; gastrin-17, synthetic rat; Saline; BSA; SC; Rat; 2ML1; 2ML2; 1, 2, 6, 13 days; Controls received mp w/ agent and no induced ulcer; functionality of mp verified by plasma gastrin levels; multiple pumps per animal (2); animal info (female, Sprague-Dawley, 200-250 g); mp primed overnight in 37C s.

P7531 Schweda,F., Segerer,F., Castrop,H., Schnermann,J., Kurtz,A. Blood pressure-dependent inhibition of renin secretion requires A1 adenosine receptors. Hypertension 2005; 46(-4-):780-786. >>> Phenylephrine; Saline, physiological; SC; Mice; 72 hours; Controls received mp w/ vehicle; functionality of mp verified by blood pressure response; comparison of SC injections vs. mp; animal info (female and male, 25-30 g, A1AR -1- or wt).

P7530 Saito,K., Ishizaka,N., Hara,M., Matsuzaki,G., Sata,M., Mori,I., Ohno,M., Nagai,R. Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II. Hypertension 2005; 46(-5-):1180-1185. >>> Angiotensin II, val 5 -; norepinephrine; SC; Rat; 2001; 7 days; Controls received no treatment; functionality of mp verified by systolic blood pressure; cardiovascular; peptides; animal info (male, Sprague-Dawley, 250-300 g); lipotoxicity.

P7526 Toyoshima,Y., Gavrilova,O., Yakar,S., Jou,W., Pack,S., Asghar,Z., Wheeler,M.B., LeRoith,D. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 2005; 146(-9-):4024-4035. >>> Leptin; SC; Mice; 2002; 14 days; Controls received mp w/ saline; functionality of mp verified by serum leptin levels; replacement t